<full-text-retrieval-response xmlns="http://www.elsevier.com/xml/svapi/article/dtd" xmlns:bk="http://www.elsevier.com/xml/bk/dtd" xmlns:cals="http://www.elsevier.com/xml/common/cals/dtd" xmlns:ce="http://www.elsevier.com/xml/common/dtd" xmlns:ja="http://www.elsevier.com/xml/ja/dtd" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:sa="http://www.elsevier.com/xml/common/struct-aff/dtd" xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd" xmlns:tb="http://www.elsevier.com/xml/common/table/dtd" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xocs="http://www.elsevier.com/xml/xocs/dtd" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><coredata><prism:url>https://api.elsevier.com/content/article/pii/S0043135405002940</prism:url><dc:identifier>doi:10.1016/j.watres.2005.05.040</dc:identifier><eid>1-s2.0-S0043135405002940</eid><prism:doi>10.1016/j.watres.2005.05.040</prism:doi><pii>S0043-1354(05)00294-0</pii><dc:title>Oxidation of pharmaceuticals during water treatment with chlorine dioxide </dc:title><prism:publicationName>Water Research</prism:publicationName><prism:aggregationType>Journal</prism:aggregationType><pubType>fla</pubType><prism:issn>00431354</prism:issn><prism:volume>39</prism:volume><prism:issueIdentifier>15</prism:issueIdentifier><prism:startingPage>3607</prism:startingPage><prism:endingPage>3617</prism:endingPage><prism:pageRange>3607-3617</prism:pageRange><prism:number>15</prism:number><dc:format>text/xml</dc:format><prism:coverDate>2005-09-30</prism:coverDate><prism:coverDisplayDate>September 2005</prism:coverDisplayDate><prism:copyright>Copyright © 2005 Elsevier Ltd. All rights reserved.</prism:copyright><prism:publisher>Elsevier Ltd.</prism:publisher><dc:creator>Huber, Marc M.</dc:creator><dc:creator>Korhonen, Susanna</dc:creator><dc:creator>Ternes, Thomas A.</dc:creator><dc:creator>von Gunten, Urs</dc:creator><dc:description>
                  The potential of chlorine dioxide (ClO2) for the oxidation of pharmaceuticals during water treatment was assessed by determining second-order rate constants for the reaction with selected environmentally relevant pharmaceuticals. Out of 9 pharmaceuticals only the 4 following compounds showed an appreciable reactivity with ClO2 (in brackets apparent second-order rate constants at pH 7 and 
                        
                           T
                           =
                           20
                           
                           °
                           
                              C
                           
                        
                     ): the sulfonamide antibiotic sulfamethoxazole (6.7×103
                     M−1
                     s−1), the macrolide antibiotic roxithromycin (2.2×102
                     M−1
                     s−1), the estrogen 17α-ethinylestradiol (∼2×105
                     M−1
                     s−1), and the antiphlogistic diclofenac (1.05×104
                     M−1
                     s−1). Experiments performed using natural water showed that ClO2 also reacted fast with other sulfonamides and macrolides, the natural hormones estrone and 17β-estradiol as well as 3 pyrazolone derivatives (phenazone, propylphenazone, and dimethylaminophenazone). However, many compounds in the study were ClO2 refractive. Experiments with lake water and groundwater that were partly performed at microgram/L to nanogram/L levels proved that the rate constants determined in pure water could be applied to predict the oxidation of pharmaceuticals in natural waters. Compared to ozone, ClO2 reacted more slowly and with fewer compounds. However, it reacted faster with the investigated compounds than chlorine. Overall, the results indicate that ClO2 will only be effective to oxidize certain compound classes such as the investigated classes of sulfonamide and macrolide antibiotics, and estrogens.
               </dc:description><openaccess>0</openaccess><openaccessArticle>false</openaccessArticle><openaccessType/><openArchiveArticle>false</openArchiveArticle><openaccessSponsorName/><openaccessSponsorType/><openaccessUserLicense/><dcterms:subject>Water treatment</dcterms:subject><dcterms:subject>Chlorine dioxide</dcterms:subject><dcterms:subject>Pharmaceuticals</dcterms:subject><dcterms:subject>Rate constants</dcterms:subject><dcterms:subject>Antibiotics</dcterms:subject><dcterms:subject>Estrogens</dcterms:subject><link href="https://api.elsevier.com/content/article/pii/S0043135405002940" rel="self"/><link href="https://www.sciencedirect.com/science/article/pii/S0043135405002940" rel="scidir"/></coredata><objects><object ref="si9" category="thumbnail" type="ALTIMG" multimediatype="GIF image file" mimetype="image/gif" width="33" height="11" size="178">https://api.elsevier.com/content/object/eid/1-s2.0-S0043135405002940-si9.gif?httpAccept=%2A%2F%2A</object><object ref="si8" category="thumbnail" type="ALTIMG" multimediatype="GIF image file" mimetype="image/gif" width="64" height="13" size="303">https://api.elsevier.com/content/object/eid/1-s2.0-S0043135405002940-si8.gif?httpAccept=%2A%2F%2A</object><object ref="si7" category="thumbnail" type="ALTIMG" multimediatype="GIF image file" mimetype="image/gif" width="118" height="15" size="471">https://api.elsevier.com/content/object/eid/1-s2.0-S0043135405002940-si7.gif?httpAccept=%2A%2F%2A</object><object ref="si6" category="thumbnail" type="ALTIMG" multimediatype="GIF image file" mimetype="image/gif" width="64" height="12" size="293">https://api.elsevier.com/content/object/eid/1-s2.0-S0043135405002940-si6.gif?httpAccept=%2A%2F%2A</object><object ref="si5" category="thumbnail" type="ALTIMG" multimediatype="GIF image file" mimetype="image/gif" width="46" height="12" size="195">https://api.elsevier.com/content/object/eid/1-s2.0-S0043135405002940-si5.gif?httpAccept=%2A%2F%2A</object><object ref="si4" category="thumbnail" type="ALTIMG" multimediatype="GIF image file" mimetype="image/gif" width="31" height="15" size="220">https://api.elsevier.com/content/object/eid/1-s2.0-S0043135405002940-si4.gif?httpAccept=%2A%2F%2A</object><object ref="si3" category="thumbnail" type="ALTIMG" multimediatype="GIF image file" mimetype="image/gif" width="69" height="19" size="442">https://api.elsevier.com/content/object/eid/1-s2.0-S0043135405002940-si3.gif?httpAccept=%2A%2F%2A</object><object ref="si2" category="thumbnail" type="ALTIMG" multimediatype="GIF image file" mimetype="image/gif" width="31" height="15" size="220">https://api.elsevier.com/content/object/eid/1-s2.0-S0043135405002940-si2.gif?httpAccept=%2A%2F%2A</object><object ref="si19" category="thumbnail" type="ALTIMG" multimediatype="GIF image file" mimetype="image/gif" width="31" height="15" size="220">https://api.elsevier.com/content/object/eid/1-s2.0-S0043135405002940-si19.gif?httpAccept=%2A%2F%2A</object><object ref="si18" category="thumbnail" type="ALTIMG" multimediatype="GIF image file" mimetype="image/gif" width="31" height="15" size="220">https://api.elsevier.com/content/object/eid/1-s2.0-S0043135405002940-si18.gif?httpAccept=%2A%2F%2A</object><object ref="si17" category="thumbnail" type="ALTIMG" multimediatype="GIF image file" mimetype="image/gif" width="64" height="12" size="293">https://api.elsevier.com/content/object/eid/1-s2.0-S0043135405002940-si17.gif?httpAccept=%2A%2F%2A</object><object ref="si16" category="thumbnail" type="ALTIMG" multimediatype="GIF image file" mimetype="image/gif" width="59" height="13" size="279">https://api.elsevier.com/content/object/eid/1-s2.0-S0043135405002940-si16.gif?httpAccept=%2A%2F%2A</object><object ref="si15" category="thumbnail" type="ALTIMG" multimediatype="GIF image file" mimetype="image/gif" width="64" height="12" size="293">https://api.elsevier.com/content/object/eid/1-s2.0-S0043135405002940-si15.gif?httpAccept=%2A%2F%2A</object><object ref="si14" category="thumbnail" type="ALTIMG" multimediatype="GIF image file" mimetype="image/gif" width="59" height="13" size="279">https://api.elsevier.com/content/object/eid/1-s2.0-S0043135405002940-si14.gif?httpAccept=%2A%2F%2A</object><object ref="si13" category="thumbnail" type="ALTIMG" multimediatype="GIF image file" mimetype="image/gif" width="64" height="12" size="293">https://api.elsevier.com/content/object/eid/1-s2.0-S0043135405002940-si13.gif?httpAccept=%2A%2F%2A</object><object ref="si12" category="thumbnail" type="ALTIMG" multimediatype="GIF image file" mimetype="image/gif" width="48" height="14" size="261">https://api.elsevier.com/content/object/eid/1-s2.0-S0043135405002940-si12.gif?httpAccept=%2A%2F%2A</object><object ref="si11" category="thumbnail" type="ALTIMG" multimediatype="GIF image file" mimetype="image/gif" width="64" height="12" size="293">https://api.elsevier.com/content/object/eid/1-s2.0-S0043135405002940-si11.gif?httpAccept=%2A%2F%2A</object><object ref="si10" category="thumbnail" type="ALTIMG" multimediatype="GIF image file" mimetype="image/gif" width="48" height="14" size="261">https://api.elsevier.com/content/object/eid/1-s2.0-S0043135405002940-si10.gif?httpAccept=%2A%2F%2A</object><object ref="si1" category="thumbnail" type="ALTIMG" multimediatype="GIF image file" mimetype="image/gif" width="144" height="35" size="768">https://api.elsevier.com/content/object/eid/1-s2.0-S0043135405002940-si1.gif?httpAccept=%2A%2F%2A</object><object ref="gr1" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="333" height="251" size="24585">https://api.elsevier.com/content/object/eid/1-s2.0-S0043135405002940-gr1.jpg?httpAccept=%2A%2F%2A</object><object ref="gr1" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="124" height="93" size="2396">https://api.elsevier.com/content/object/eid/1-s2.0-S0043135405002940-gr1.sml?httpAccept=%2A%2F%2A</object><object ref="gr4" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="333" height="210" size="20623">https://api.elsevier.com/content/object/eid/1-s2.0-S0043135405002940-gr4.jpg?httpAccept=%2A%2F%2A</object><object ref="gr4" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="125" height="79" size="2185">https://api.elsevier.com/content/object/eid/1-s2.0-S0043135405002940-gr4.sml?httpAccept=%2A%2F%2A</object><object ref="gr6" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="709" height="336" size="60254">https://api.elsevier.com/content/object/eid/1-s2.0-S0043135405002940-gr6.jpg?httpAccept=%2A%2F%2A</object><object ref="gr6" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="125" height="59" size="2422">https://api.elsevier.com/content/object/eid/1-s2.0-S0043135405002940-gr6.sml?httpAccept=%2A%2F%2A</object><object ref="gr3" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="333" height="213" size="26667">https://api.elsevier.com/content/object/eid/1-s2.0-S0043135405002940-gr3.jpg?httpAccept=%2A%2F%2A</object><object ref="gr3" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="125" height="80" size="2940">https://api.elsevier.com/content/object/eid/1-s2.0-S0043135405002940-gr3.sml?httpAccept=%2A%2F%2A</object><object ref="gr2" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="333" height="243" size="24087">https://api.elsevier.com/content/object/eid/1-s2.0-S0043135405002940-gr2.jpg?httpAccept=%2A%2F%2A</object><object ref="gr2" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="125" height="91" size="2425">https://api.elsevier.com/content/object/eid/1-s2.0-S0043135405002940-gr2.sml?httpAccept=%2A%2F%2A</object><object ref="gr7" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="332" height="223" size="23843">https://api.elsevier.com/content/object/eid/1-s2.0-S0043135405002940-gr7.jpg?httpAccept=%2A%2F%2A</object><object ref="gr7" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="125" height="84" size="2450">https://api.elsevier.com/content/object/eid/1-s2.0-S0043135405002940-gr7.sml?httpAccept=%2A%2F%2A</object><object ref="gr5" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="332" height="198" size="24923">https://api.elsevier.com/content/object/eid/1-s2.0-S0043135405002940-gr5.jpg?httpAccept=%2A%2F%2A</object><object ref="gr5" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="125" height="74" size="2648">https://api.elsevier.com/content/object/eid/1-s2.0-S0043135405002940-gr5.sml?httpAccept=%2A%2F%2A</object><object ref="gr8" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="332" height="533" size="63723">https://api.elsevier.com/content/object/eid/1-s2.0-S0043135405002940-gr8.jpg?httpAccept=%2A%2F%2A</object><object ref="gr8" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="58" height="93" size="2457">https://api.elsevier.com/content/object/eid/1-s2.0-S0043135405002940-gr8.sml?httpAccept=%2A%2F%2A</object></objects><scopus-id>24344452948</scopus-id><scopus-eid>2-s2.0-24344452948</scopus-eid><pubmed-id>16061268</pubmed-id><link href="https://api.elsevier.com/content/abstract/scopus_id/24344452948" rel="abstract"/><originalText><xocs:doc xsi:schemaLocation="http://www.elsevier.com/xml/xocs/dtd http://null/schema/dtds/document/fulltext/xcr/xocs-article.xsd"><xocs:meta xmlns:xoe="http://www.elsevier.com/xml/xoe/dtd">
      <xocs:content-family>serial</xocs:content-family>
      <xocs:content-type>JL</xocs:content-type>
      <xocs:cid>271768</xocs:cid>
      <xocs:ssids>
         <xocs:ssid type="alllist">291210</xocs:ssid>
         <xocs:ssid type="subj">291798</xocs:ssid>
         <xocs:ssid type="subj">291830</xocs:ssid>
         <xocs:ssid type="content">31</xocs:ssid>
      </xocs:ssids>
      <xocs:srctitle>Water Research</xocs:srctitle>
      <xocs:normalized-srctitle>WATERRESEARCH</xocs:normalized-srctitle>
      <xocs:orig-load-date yyyymmdd="20050801">2005-08-01</xocs:orig-load-date>
      <xocs:available-online-date yyyymmdd="20050801">2005-08-01</xocs:available-online-date>
      <xocs:ew-transaction-id>2010-11-13T19:24:29</xocs:ew-transaction-id>
      <xocs:eid>1-s2.0-S0043135405002940</xocs:eid>
      <xocs:pii-formatted>S0043-1354(05)00294-0</xocs:pii-formatted>
      <xocs:pii-unformatted>S0043135405002940</xocs:pii-unformatted>
      <xocs:doi>10.1016/j.watres.2005.05.040</xocs:doi>
      <xocs:item-stage>S300</xocs:item-stage>
      <xocs:item-version-number>S300.1</xocs:item-version-number>
      <xocs:item-weight>FULL-TEXT</xocs:item-weight>
      <xocs:hub-eid>1-s2.0-S0043135405X0522X</xocs:hub-eid>
      <xocs:timestamp yyyymmdd="20150514">2015-05-14T02:56:28.170761-04:00</xocs:timestamp>
      <xocs:dco>0</xocs:dco>
      <xocs:tomb>0</xocs:tomb>
      <xocs:date-search-begin>20050901</xocs:date-search-begin>
      <xocs:date-search-end>20050930</xocs:date-search-end>
      <xocs:year-nav>2005</xocs:year-nav>
      <xocs:indexeddate epoch="1122854400">2005-08-01T00:00:00Z</xocs:indexeddate>
      <xocs:articleinfo>articleinfo crossmark dco dateupdated tomb dateloaded datesearch indexeddate issuelist volumelist yearnav absattachment articletitlenorm authfirstinitialnorm authfirstsurnamenorm cid cids contenttype copyright dateloadedtxt docsubtype doctype doi eid ewtransactionid hubeid issfirst issn issnnorm itemstage itemtransactionid itemweight openaccess openarchive pg pgfirst pglast pii piinorm pubdateend pubdatestart pubdatetxt pubyr sectiontitle sortorder srctitle srctitlenorm srctype subheadings volfirst volissue webpdf webpdfpagecount figure table body mmlmath acknowledge affil articletitle auth authfirstini authfull authkeywords authlast primabst ref alllist content subj ssids</xocs:articleinfo>
      <xocs:issns>
         <xocs:issn-primary-formatted>0043-1354</xocs:issn-primary-formatted>
         <xocs:issn-primary-unformatted>00431354</xocs:issn-primary-unformatted>
      </xocs:issns>
      <xocs:crossmark is-crossmark="0"/>
      <xocs:vol-first>39</xocs:vol-first>
      <xocs:volume-list>
         <xocs:volume>39</xocs:volume>
      </xocs:volume-list>
      <xocs:iss-first>15</xocs:iss-first>
      <xocs:issue-list>
         <xocs:issue>15</xocs:issue>
      </xocs:issue-list>
      <xocs:vol-iss-suppl-text>Volume 39, Issue 15</xocs:vol-iss-suppl-text>
      <xocs:sort-order>19</xocs:sort-order>
      <xocs:first-fp>3607</xocs:first-fp>
      <xocs:last-lp>3617</xocs:last-lp>
      <xocs:pages>
         <xocs:first-page>3607</xocs:first-page>
         <xocs:last-page>3617</xocs:last-page>
      </xocs:pages>
      <xocs:cover-date-orig>
         <xocs:start-date>200509</xocs:start-date>
      </xocs:cover-date-orig>
      <xocs:cover-date-text>September 2005</xocs:cover-date-text>
      <xocs:cover-date-start>2005-09-01</xocs:cover-date-start>
      <xocs:cover-date-end>2005-09-30</xocs:cover-date-end>
      <xocs:cover-date-year>2005</xocs:cover-date-year>
      <xocs:hub-sec>
         <xocs:hub-sec-title>Full papers</xocs:hub-sec-title>
      </xocs:hub-sec>
      <xocs:document-type>article</xocs:document-type>
      <xocs:document-subtype>fla</xocs:document-subtype>
      <xocs:copyright-line>Copyright © 2005 Elsevier Ltd. All rights reserved.</xocs:copyright-line>
      <xocs:normalized-article-title>OXIDATIONPHARMACEUTICALSDURINGWATERTREATMENTCHLORINEDIOXIDE</xocs:normalized-article-title>
      <xocs:normalized-first-auth-surname>HUBER</xocs:normalized-first-auth-surname>
      <xocs:normalized-first-auth-initial>M</xocs:normalized-first-auth-initial>
      <xocs:item-toc>
         <xocs:item-toc-entry ref-elem="ce:sections">
            <xocs:item-toc-label>1</xocs:item-toc-label>
            <xocs:item-toc-section-title>Introduction</xocs:item-toc-section-title>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>1.1</xocs:item-toc-label>
               <xocs:item-toc-section-title>Pharmaceuticals in the environment</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>1.2</xocs:item-toc-label>
               <xocs:item-toc-section-title>Application of chlorine dioxide for water treatment</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>1.3</xocs:item-toc-label>
               <xocs:item-toc-section-title>Chemical aspects of chlorine dioxide</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>1.4</xocs:item-toc-label>
               <xocs:item-toc-section-title>Objectives of the present study</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:sections">
            <xocs:item-toc-label>2</xocs:item-toc-label>
            <xocs:item-toc-section-title>Experimental methods</xocs:item-toc-section-title>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.1</xocs:item-toc-label>
               <xocs:item-toc-section-title>Chemicals</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.2</xocs:item-toc-label>
               <xocs:item-toc-section-title>Analytical methods</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.3</xocs:item-toc-label>
               <xocs:item-toc-section-title>Determination of rate constants</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.4</xocs:item-toc-label>
               <xocs:item-toc-section-title>Oxidation in drinking water</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.5</xocs:item-toc-label>
               <xocs:item-toc-section-title>Oxidation in lake water</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.6</xocs:item-toc-label>
               <xocs:item-toc-section-title>Oxidation in groundwater</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:sections">
            <xocs:item-toc-label>3</xocs:item-toc-label>
            <xocs:item-toc-section-title>Results and discussion</xocs:item-toc-section-title>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>3.1</xocs:item-toc-label>
               <xocs:item-toc-section-title>Oxidation in drinking water</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>3.2</xocs:item-toc-label>
               <xocs:item-toc-section-title>Oxidation in lake water</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>3.3</xocs:item-toc-label>
               <xocs:item-toc-section-title>Oxidation in groundwater</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>3.4</xocs:item-toc-label>
               <xocs:item-toc-section-title>Oxidation products</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>3.5</xocs:item-toc-label>
               <xocs:item-toc-section-title>Comparison of chlorine dioxide with ozone and chlorine</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:sections">
            <xocs:item-toc-label>4</xocs:item-toc-label>
            <xocs:item-toc-section-title>Conclusions</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:acknowledgment">
            <xocs:item-toc-section-title>Acknowledgments</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:bibliography">
            <xocs:item-toc-section-title>References</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
      </xocs:item-toc>
      <xocs:references>
         <xocs:ref-info refid="bib1">
            <xocs:ref-normalized-surname>ABIA</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1998</xocs:ref-pub-year>
            <xocs:ref-first-fp>521</xocs:ref-first-fp>
            <xocs:ref-last-lp>530</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>L</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="bib2">
            <xocs:ref-normalized-surname>CHEN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2002</xocs:ref-pub-year>
            <xocs:ref-first-fp>371</xocs:ref-first-fp>
            <xocs:ref-last-lp>394</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
            <xocs:ref-normalized-srctitle>INFORMATIONCOLLECTIONRULEANALYSISDATA</xocs:ref-normalized-srctitle>
            <xocs:ref-normalized-article-title>DISINFECTIONPRACTICESPATHOGENINACTIVATIONINICRSURFACEWATERPLANTS</xocs:ref-normalized-article-title>
         </xocs:ref-info>
         <xocs:ref-info refid="bib3">
            <xocs:ref-normalized-surname>CHISWELL</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1991</xocs:ref-pub-year>
            <xocs:ref-first-fp>657</xocs:ref-first-fp>
            <xocs:ref-last-lp>661</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>B</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="bib4"/>
         <xocs:ref-info refid="bib5"/>
         <xocs:ref-info refid="bib6"/>
         <xocs:ref-info refid="bib7">
            <xocs:ref-normalized-surname>GATES</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1998</xocs:ref-pub-year>
            <xocs:ref-normalized-initial>D</xocs:ref-normalized-initial>
            <xocs:ref-normalized-srctitle>CHLORINEDIOXIDEHANDBOOK</xocs:ref-normalized-srctitle>
         </xocs:ref-info>
         <xocs:ref-info refid="bib8">
            <xocs:ref-normalized-surname>GOBEL</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2004</xocs:ref-pub-year>
            <xocs:ref-first-fp>4756</xocs:ref-first-fp>
            <xocs:ref-last-lp>4764</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>A</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="bib9">
            <xocs:ref-normalized-surname>HIRSCH</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1999</xocs:ref-pub-year>
            <xocs:ref-first-fp>109</xocs:ref-first-fp>
            <xocs:ref-last-lp>118</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>R</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="bib10">
            <xocs:ref-normalized-surname>HOIGNE</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1994</xocs:ref-pub-year>
            <xocs:ref-first-fp>45</xocs:ref-first-fp>
            <xocs:ref-last-lp>55</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="bib11">
            <xocs:ref-normalized-surname>HUBER</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2003</xocs:ref-pub-year>
            <xocs:ref-first-fp>1016</xocs:ref-first-fp>
            <xocs:ref-last-lp>1024</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="bib12">
            <xocs:ref-normalized-surname>HUBER</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2004</xocs:ref-pub-year>
            <xocs:ref-first-fp>5177</xocs:ref-first-fp>
            <xocs:ref-last-lp>5186</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="bib13">
            <xocs:ref-normalized-surname>KOLPIN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2002</xocs:ref-pub-year>
            <xocs:ref-first-fp>1202</xocs:ref-first-fp>
            <xocs:ref-last-lp>1211</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>D</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="bib14">
            <xocs:ref-normalized-surname>LI</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2001</xocs:ref-pub-year>
            <xocs:ref-first-fp>469</xocs:ref-first-fp>
            <xocs:ref-last-lp>474</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>X</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="bib15">
            <xocs:ref-normalized-surname>LOFFLER</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2003</xocs:ref-pub-year>
            <xocs:ref-first-fp>133</xocs:ref-first-fp>
            <xocs:ref-last-lp>144</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>D</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="bib16">
            <xocs:ref-normalized-surname>PATTISON</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2001</xocs:ref-pub-year>
            <xocs:ref-first-fp>1453</xocs:ref-first-fp>
            <xocs:ref-last-lp>1464</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>D</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="bib17">
            <xocs:ref-normalized-surname>PINKERNELL</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2000</xocs:ref-pub-year>
            <xocs:ref-first-fp>4343</xocs:ref-first-fp>
            <xocs:ref-last-lp>4350</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>U</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="bib18">
            <xocs:ref-normalized-surname>PINKSTON</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2004</xocs:ref-pub-year>
            <xocs:ref-first-fp>4019</xocs:ref-first-fp>
            <xocs:ref-last-lp>4025</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>K</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="bib19"/>
         <xocs:ref-info refid="bib20">
            <xocs:ref-normalized-surname>RAVACHA</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1984</xocs:ref-pub-year>
            <xocs:ref-first-fp>1329</xocs:ref-first-fp>
            <xocs:ref-last-lp>1341</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>C</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="bib21">
            <xocs:ref-normalized-surname>REDDERSEN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2002</xocs:ref-pub-year>
            <xocs:ref-normalized-initial>K</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="bib22">
            <xocs:ref-normalized-surname>ROSENBLATT</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1967</xocs:ref-pub-year>
            <xocs:ref-first-fp>1158</xocs:ref-first-fp>
            <xocs:ref-last-lp>1163</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>D</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="bib23">
            <xocs:ref-normalized-surname>SACHER</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2001</xocs:ref-pub-year>
            <xocs:ref-first-fp>199</xocs:ref-first-fp>
            <xocs:ref-last-lp>210</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>F</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="bib24">
            <xocs:ref-normalized-surname>SCHONENBERGER</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2003</xocs:ref-pub-year>
            <xocs:ref-normalized-initial>R</xocs:ref-normalized-initial>
            <xocs:ref-normalized-srctitle>STANDARDOPERATINGPROCEDUREFORDETERMINATIONSTEROIDHORMONESUSINGLCMSMS</xocs:ref-normalized-srctitle>
         </xocs:ref-info>
         <xocs:ref-info refid="bib25">
            <xocs:ref-normalized-surname>STACKELBERG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2004</xocs:ref-pub-year>
            <xocs:ref-first-fp>99</xocs:ref-first-fp>
            <xocs:ref-last-lp>113</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>P</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="bib26">
            <xocs:ref-normalized-surname>TERNES</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1998</xocs:ref-pub-year>
            <xocs:ref-first-fp>3245</xocs:ref-first-fp>
            <xocs:ref-last-lp>3260</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>T</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="bib27"/>
         <xocs:ref-info refid="bib28">
            <xocs:ref-normalized-surname>TERNES</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2000</xocs:ref-pub-year>
            <xocs:ref-first-fp>2741</xocs:ref-first-fp>
            <xocs:ref-last-lp>2748</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>T</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="bib29">
            <xocs:ref-normalized-surname>TERNES</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1998</xocs:ref-pub-year>
            <xocs:ref-first-fp>329</xocs:ref-first-fp>
            <xocs:ref-last-lp>340</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>T</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="bib30">
            <xocs:ref-normalized-surname>TERNES</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2002</xocs:ref-pub-year>
            <xocs:ref-first-fp>3855</xocs:ref-first-fp>
            <xocs:ref-last-lp>3863</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>T</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="bib31"/>
         <xocs:ref-info refid="bib32"/>
         <xocs:ref-info refid="bib33">
            <xocs:ref-normalized-surname>WEBB</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2003</xocs:ref-pub-year>
            <xocs:ref-first-fp>157</xocs:ref-first-fp>
            <xocs:ref-last-lp>167</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>S</xocs:ref-normalized-initial>
         </xocs:ref-info>
      </xocs:references>
      <xocs:refkeys>
         <xocs:refkey3>HUBERX2005X3607</xocs:refkey3>
         <xocs:refkey4lp>HUBERX2005X3607X3617</xocs:refkey4lp>
         <xocs:refkey4ai>HUBERX2005X3607XM</xocs:refkey4ai>
         <xocs:refkey5>HUBERX2005X3607X3617XM</xocs:refkey5>
      </xocs:refkeys>
      <xocs:open-access>
         <xocs:oa-article-status is-open-access="0" is-open-archive="0"/>
      </xocs:open-access>
      <xocs:attachment-metadata-doc>
         <xocs:attachment-set-type>item</xocs:attachment-set-type>
         <xocs:pii-formatted>S0043-1354(05)00294-0</xocs:pii-formatted>
         <xocs:pii-unformatted>S0043135405002940</xocs:pii-unformatted>
         <xocs:eid>1-s2.0-S0043135405002940</xocs:eid>
         <xocs:doi>10.1016/j.watres.2005.05.040</xocs:doi>
         <xocs:cid>271768</xocs:cid>
         <xocs:timestamp>2010-12-24T02:09:15.720576-05:00</xocs:timestamp>
         <xocs:cover-date-start>2005-09-01</xocs:cover-date-start>
         <xocs:cover-date-end>2005-09-30</xocs:cover-date-end>
         <xocs:attachments>
            <xocs:web-pdf>
               <xocs:attachment-eid>1-s2.0-S0043135405002940-main.pdf</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0043135405002940/MAIN/application/pdf/f250d5ea40242a7bcdc44b6695b67b72/main.pdf</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0043135405002940/MAIN/application/pdf/f250d5ea40242a7bcdc44b6695b67b72/main.pdf</xocs:ucs-locator>
               <xocs:filename>main.pdf</xocs:filename>
               <xocs:extension>pdf</xocs:extension>
               <xocs:pdf-optimized>true</xocs:pdf-optimized>
               <xocs:filesize>365387</xocs:filesize>
               <xocs:web-pdf-purpose>MAIN</xocs:web-pdf-purpose>
               <xocs:web-pdf-page-count>11</xocs:web-pdf-page-count>
               <xocs:web-pdf-images>
                  <xocs:web-pdf-image>
                     <xocs:attachment-eid>1-s2.0-S0043135405002940-main_1.png</xocs:attachment-eid>
                     <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0043135405002940/PREVIEW/image/png/cae6af30083c9dab3fdd9d43904266e7/main_1.png</xocs:ucs-locator>
                     <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0043135405002940/PREVIEW/image/png/cae6af30083c9dab3fdd9d43904266e7/main_1.png</xocs:ucs-locator>
                     <xocs:filename>main_1.png</xocs:filename>
                     <xocs:extension>png</xocs:extension>
                     <xocs:filesize>60928</xocs:filesize>
                     <xocs:pixel-height>849</xocs:pixel-height>
                     <xocs:pixel-width>656</xocs:pixel-width>
                     <xocs:attachment-type>IMAGE-WEB-PDF</xocs:attachment-type>
                     <xocs:pdf-page-num>1</xocs:pdf-page-num>
                  </xocs:web-pdf-image>
               </xocs:web-pdf-images>
            </xocs:web-pdf>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0043135405002940-si9.gif</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0043135405002940/STRIPIN/image/gif/f9609429e047eff6b6a782cb495fe36c/si9.gif</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0043135405002940/STRIPIN/image/gif/f9609429e047eff6b6a782cb495fe36c/si9.gif</xocs:ucs-locator>
               <xocs:file-basename>si9</xocs:file-basename>
               <xocs:filename>si9.gif</xocs:filename>
               <xocs:extension>gif</xocs:extension>
               <xocs:filesize>178</xocs:filesize>
               <xocs:pixel-height>11</xocs:pixel-height>
               <xocs:pixel-width>33</xocs:pixel-width>
               <xocs:attachment-type>ALTIMG</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0043135405002940-si8.gif</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0043135405002940/STRIPIN/image/gif/47c63492fb070c1f2c67274a5ddf311f/si8.gif</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0043135405002940/STRIPIN/image/gif/47c63492fb070c1f2c67274a5ddf311f/si8.gif</xocs:ucs-locator>
               <xocs:file-basename>si8</xocs:file-basename>
               <xocs:filename>si8.gif</xocs:filename>
               <xocs:extension>gif</xocs:extension>
               <xocs:filesize>303</xocs:filesize>
               <xocs:pixel-height>13</xocs:pixel-height>
               <xocs:pixel-width>64</xocs:pixel-width>
               <xocs:attachment-type>ALTIMG</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0043135405002940-si7.gif</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0043135405002940/STRIPIN/image/gif/e3602a98f9613fcc220bbcc39253f483/si7.gif</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0043135405002940/STRIPIN/image/gif/e3602a98f9613fcc220bbcc39253f483/si7.gif</xocs:ucs-locator>
               <xocs:file-basename>si7</xocs:file-basename>
               <xocs:filename>si7.gif</xocs:filename>
               <xocs:extension>gif</xocs:extension>
               <xocs:filesize>471</xocs:filesize>
               <xocs:pixel-height>15</xocs:pixel-height>
               <xocs:pixel-width>118</xocs:pixel-width>
               <xocs:attachment-type>ALTIMG</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0043135405002940-si6.gif</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0043135405002940/STRIPIN/image/gif/cb37e30a4e6c4de1bb8c41e5d488b9db/si6.gif</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0043135405002940/STRIPIN/image/gif/cb37e30a4e6c4de1bb8c41e5d488b9db/si6.gif</xocs:ucs-locator>
               <xocs:file-basename>si6</xocs:file-basename>
               <xocs:abstract-attachment>true</xocs:abstract-attachment>
               <xocs:filename>si6.gif</xocs:filename>
               <xocs:extension>gif</xocs:extension>
               <xocs:filesize>293</xocs:filesize>
               <xocs:pixel-height>12</xocs:pixel-height>
               <xocs:pixel-width>64</xocs:pixel-width>
               <xocs:attachment-type>ALTIMG</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0043135405002940-si5.gif</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0043135405002940/STRIPIN/image/gif/a1beb87fee9bed3b2653ab7cd735b4a2/si5.gif</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0043135405002940/STRIPIN/image/gif/a1beb87fee9bed3b2653ab7cd735b4a2/si5.gif</xocs:ucs-locator>
               <xocs:file-basename>si5</xocs:file-basename>
               <xocs:filename>si5.gif</xocs:filename>
               <xocs:extension>gif</xocs:extension>
               <xocs:filesize>195</xocs:filesize>
               <xocs:pixel-height>12</xocs:pixel-height>
               <xocs:pixel-width>46</xocs:pixel-width>
               <xocs:attachment-type>ALTIMG</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0043135405002940-si4.gif</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0043135405002940/STRIPIN/image/gif/ececaa0dffa2c414d9895f812807e48e/si2.gif</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0043135405002940/STRIPIN/image/gif/ececaa0dffa2c414d9895f812807e48e/si2.gif</xocs:ucs-locator>
               <xocs:file-basename>si4</xocs:file-basename>
               <xocs:filename>si4.gif</xocs:filename>
               <xocs:extension>gif</xocs:extension>
               <xocs:filesize>220</xocs:filesize>
               <xocs:pixel-height>15</xocs:pixel-height>
               <xocs:pixel-width>31</xocs:pixel-width>
               <xocs:attachment-type>ALTIMG</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0043135405002940-si3.gif</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0043135405002940/STRIPIN/image/gif/82a81ae4a49eb4ca335d41ab4984b88e/si3.gif</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0043135405002940/STRIPIN/image/gif/82a81ae4a49eb4ca335d41ab4984b88e/si3.gif</xocs:ucs-locator>
               <xocs:file-basename>si3</xocs:file-basename>
               <xocs:filename>si3.gif</xocs:filename>
               <xocs:extension>gif</xocs:extension>
               <xocs:filesize>442</xocs:filesize>
               <xocs:pixel-height>19</xocs:pixel-height>
               <xocs:pixel-width>69</xocs:pixel-width>
               <xocs:attachment-type>ALTIMG</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0043135405002940-si2.gif</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0043135405002940/STRIPIN/image/gif/ececaa0dffa2c414d9895f812807e48e/si2.gif</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0043135405002940/STRIPIN/image/gif/ececaa0dffa2c414d9895f812807e48e/si2.gif</xocs:ucs-locator>
               <xocs:file-basename>si2</xocs:file-basename>
               <xocs:filename>si2.gif</xocs:filename>
               <xocs:extension>gif</xocs:extension>
               <xocs:filesize>220</xocs:filesize>
               <xocs:pixel-height>15</xocs:pixel-height>
               <xocs:pixel-width>31</xocs:pixel-width>
               <xocs:attachment-type>ALTIMG</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0043135405002940-si19.gif</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0043135405002940/STRIPIN/image/gif/ececaa0dffa2c414d9895f812807e48e/si2.gif</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0043135405002940/STRIPIN/image/gif/ececaa0dffa2c414d9895f812807e48e/si2.gif</xocs:ucs-locator>
               <xocs:file-basename>si19</xocs:file-basename>
               <xocs:filename>si19.gif</xocs:filename>
               <xocs:extension>gif</xocs:extension>
               <xocs:filesize>220</xocs:filesize>
               <xocs:pixel-height>15</xocs:pixel-height>
               <xocs:pixel-width>31</xocs:pixel-width>
               <xocs:attachment-type>ALTIMG</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0043135405002940-si18.gif</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0043135405002940/STRIPIN/image/gif/ececaa0dffa2c414d9895f812807e48e/si2.gif</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0043135405002940/STRIPIN/image/gif/ececaa0dffa2c414d9895f812807e48e/si2.gif</xocs:ucs-locator>
               <xocs:file-basename>si18</xocs:file-basename>
               <xocs:filename>si18.gif</xocs:filename>
               <xocs:extension>gif</xocs:extension>
               <xocs:filesize>220</xocs:filesize>
               <xocs:pixel-height>15</xocs:pixel-height>
               <xocs:pixel-width>31</xocs:pixel-width>
               <xocs:attachment-type>ALTIMG</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0043135405002940-si17.gif</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0043135405002940/STRIPIN/image/gif/cb37e30a4e6c4de1bb8c41e5d488b9db/si6.gif</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0043135405002940/STRIPIN/image/gif/cb37e30a4e6c4de1bb8c41e5d488b9db/si6.gif</xocs:ucs-locator>
               <xocs:file-basename>si17</xocs:file-basename>
               <xocs:filename>si17.gif</xocs:filename>
               <xocs:extension>gif</xocs:extension>
               <xocs:filesize>293</xocs:filesize>
               <xocs:pixel-height>12</xocs:pixel-height>
               <xocs:pixel-width>64</xocs:pixel-width>
               <xocs:attachment-type>ALTIMG</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0043135405002940-si16.gif</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0043135405002940/STRIPIN/image/gif/7a7bb224b2881cb079542eda093a0b3e/si16.gif</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0043135405002940/STRIPIN/image/gif/7a7bb224b2881cb079542eda093a0b3e/si16.gif</xocs:ucs-locator>
               <xocs:file-basename>si16</xocs:file-basename>
               <xocs:filename>si16.gif</xocs:filename>
               <xocs:extension>gif</xocs:extension>
               <xocs:filesize>279</xocs:filesize>
               <xocs:pixel-height>13</xocs:pixel-height>
               <xocs:pixel-width>59</xocs:pixel-width>
               <xocs:attachment-type>ALTIMG</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0043135405002940-si15.gif</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0043135405002940/STRIPIN/image/gif/cb37e30a4e6c4de1bb8c41e5d488b9db/si6.gif</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0043135405002940/STRIPIN/image/gif/cb37e30a4e6c4de1bb8c41e5d488b9db/si6.gif</xocs:ucs-locator>
               <xocs:file-basename>si15</xocs:file-basename>
               <xocs:filename>si15.gif</xocs:filename>
               <xocs:extension>gif</xocs:extension>
               <xocs:filesize>293</xocs:filesize>
               <xocs:pixel-height>12</xocs:pixel-height>
               <xocs:pixel-width>64</xocs:pixel-width>
               <xocs:attachment-type>ALTIMG</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0043135405002940-si14.gif</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0043135405002940/STRIPIN/image/gif/7a7bb224b2881cb079542eda093a0b3e/si16.gif</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0043135405002940/STRIPIN/image/gif/7a7bb224b2881cb079542eda093a0b3e/si16.gif</xocs:ucs-locator>
               <xocs:file-basename>si14</xocs:file-basename>
               <xocs:filename>si14.gif</xocs:filename>
               <xocs:extension>gif</xocs:extension>
               <xocs:filesize>279</xocs:filesize>
               <xocs:pixel-height>13</xocs:pixel-height>
               <xocs:pixel-width>59</xocs:pixel-width>
               <xocs:attachment-type>ALTIMG</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0043135405002940-si13.gif</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0043135405002940/STRIPIN/image/gif/cb37e30a4e6c4de1bb8c41e5d488b9db/si6.gif</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0043135405002940/STRIPIN/image/gif/cb37e30a4e6c4de1bb8c41e5d488b9db/si6.gif</xocs:ucs-locator>
               <xocs:file-basename>si13</xocs:file-basename>
               <xocs:filename>si13.gif</xocs:filename>
               <xocs:extension>gif</xocs:extension>
               <xocs:filesize>293</xocs:filesize>
               <xocs:pixel-height>12</xocs:pixel-height>
               <xocs:pixel-width>64</xocs:pixel-width>
               <xocs:attachment-type>ALTIMG</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0043135405002940-si12.gif</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0043135405002940/STRIPIN/image/gif/31565f9e2c3b3dc9592306abed6ae320/si10.gif</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0043135405002940/STRIPIN/image/gif/31565f9e2c3b3dc9592306abed6ae320/si10.gif</xocs:ucs-locator>
               <xocs:file-basename>si12</xocs:file-basename>
               <xocs:filename>si12.gif</xocs:filename>
               <xocs:extension>gif</xocs:extension>
               <xocs:filesize>261</xocs:filesize>
               <xocs:pixel-height>14</xocs:pixel-height>
               <xocs:pixel-width>48</xocs:pixel-width>
               <xocs:attachment-type>ALTIMG</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0043135405002940-si11.gif</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0043135405002940/STRIPIN/image/gif/cb37e30a4e6c4de1bb8c41e5d488b9db/si6.gif</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0043135405002940/STRIPIN/image/gif/cb37e30a4e6c4de1bb8c41e5d488b9db/si6.gif</xocs:ucs-locator>
               <xocs:file-basename>si11</xocs:file-basename>
               <xocs:filename>si11.gif</xocs:filename>
               <xocs:extension>gif</xocs:extension>
               <xocs:filesize>293</xocs:filesize>
               <xocs:pixel-height>12</xocs:pixel-height>
               <xocs:pixel-width>64</xocs:pixel-width>
               <xocs:attachment-type>ALTIMG</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0043135405002940-si10.gif</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0043135405002940/STRIPIN/image/gif/31565f9e2c3b3dc9592306abed6ae320/si10.gif</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0043135405002940/STRIPIN/image/gif/31565f9e2c3b3dc9592306abed6ae320/si10.gif</xocs:ucs-locator>
               <xocs:file-basename>si10</xocs:file-basename>
               <xocs:filename>si10.gif</xocs:filename>
               <xocs:extension>gif</xocs:extension>
               <xocs:filesize>261</xocs:filesize>
               <xocs:pixel-height>14</xocs:pixel-height>
               <xocs:pixel-width>48</xocs:pixel-width>
               <xocs:attachment-type>ALTIMG</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0043135405002940-si1.gif</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0043135405002940/STRIPIN/image/gif/b0d9bf601da400c7c0bfafef09e80996/si1.gif</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0043135405002940/STRIPIN/image/gif/b0d9bf601da400c7c0bfafef09e80996/si1.gif</xocs:ucs-locator>
               <xocs:file-basename>si1</xocs:file-basename>
               <xocs:filename>si1.gif</xocs:filename>
               <xocs:extension>gif</xocs:extension>
               <xocs:filesize>768</xocs:filesize>
               <xocs:pixel-height>35</xocs:pixel-height>
               <xocs:pixel-width>144</xocs:pixel-width>
               <xocs:attachment-type>ALTIMG</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0043135405002940-gr1.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0043135405002940/gr1/DOWNSAMPLED/image/jpeg/2a740aa48e93364ace361a0a1e72e4a2/gr1.jpg</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0043135405002940/gr1/DOWNSAMPLED/image/jpeg/2a740aa48e93364ace361a0a1e72e4a2/gr1.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr1</xocs:file-basename>
               <xocs:filename>gr1.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>24585</xocs:filesize>
               <xocs:pixel-height>251</xocs:pixel-height>
               <xocs:pixel-width>333</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0043135405002940-gr1.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0043135405002940/gr1/THUMBNAIL/image/gif/de541ff1eaebb161ddb99e21a31670b2/gr1.sml</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0043135405002940/gr1/THUMBNAIL/image/gif/de541ff1eaebb161ddb99e21a31670b2/gr1.sml</xocs:ucs-locator>
               <xocs:file-basename>gr1</xocs:file-basename>
               <xocs:filename>gr1.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2396</xocs:filesize>
               <xocs:pixel-height>93</xocs:pixel-height>
               <xocs:pixel-width>124</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0043135405002940-gr4.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0043135405002940/gr4/DOWNSAMPLED/image/jpeg/ca4dcdc7edf2807f97442cd6ce13406e/gr4.jpg</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0043135405002940/gr4/DOWNSAMPLED/image/jpeg/ca4dcdc7edf2807f97442cd6ce13406e/gr4.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr4</xocs:file-basename>
               <xocs:filename>gr4.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>20623</xocs:filesize>
               <xocs:pixel-height>210</xocs:pixel-height>
               <xocs:pixel-width>333</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0043135405002940-gr4.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0043135405002940/gr4/THUMBNAIL/image/gif/571c46b95049b46728c7c266dad04c7d/gr4.sml</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0043135405002940/gr4/THUMBNAIL/image/gif/571c46b95049b46728c7c266dad04c7d/gr4.sml</xocs:ucs-locator>
               <xocs:file-basename>gr4</xocs:file-basename>
               <xocs:filename>gr4.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2185</xocs:filesize>
               <xocs:pixel-height>79</xocs:pixel-height>
               <xocs:pixel-width>125</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0043135405002940-gr6.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0043135405002940/gr6/DOWNSAMPLED/image/jpeg/53eb50603ba2c725c217ebb3563909ce/gr6.jpg</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0043135405002940/gr6/DOWNSAMPLED/image/jpeg/53eb50603ba2c725c217ebb3563909ce/gr6.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr6</xocs:file-basename>
               <xocs:filename>gr6.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>60254</xocs:filesize>
               <xocs:pixel-height>336</xocs:pixel-height>
               <xocs:pixel-width>709</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0043135405002940-gr6.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0043135405002940/gr6/THUMBNAIL/image/gif/ca849bf3adeab3d92d56a6ab7ce4555e/gr6.sml</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0043135405002940/gr6/THUMBNAIL/image/gif/ca849bf3adeab3d92d56a6ab7ce4555e/gr6.sml</xocs:ucs-locator>
               <xocs:file-basename>gr6</xocs:file-basename>
               <xocs:filename>gr6.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2422</xocs:filesize>
               <xocs:pixel-height>59</xocs:pixel-height>
               <xocs:pixel-width>125</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0043135405002940-gr3.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0043135405002940/gr3/DOWNSAMPLED/image/jpeg/018385dac2d08b365bbb1da6f4a9d4fa/gr3.jpg</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0043135405002940/gr3/DOWNSAMPLED/image/jpeg/018385dac2d08b365bbb1da6f4a9d4fa/gr3.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr3</xocs:file-basename>
               <xocs:filename>gr3.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>26667</xocs:filesize>
               <xocs:pixel-height>213</xocs:pixel-height>
               <xocs:pixel-width>333</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0043135405002940-gr3.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0043135405002940/gr3/THUMBNAIL/image/gif/4eb03b605c086b8af9b1872f36cd1975/gr3.sml</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0043135405002940/gr3/THUMBNAIL/image/gif/4eb03b605c086b8af9b1872f36cd1975/gr3.sml</xocs:ucs-locator>
               <xocs:file-basename>gr3</xocs:file-basename>
               <xocs:filename>gr3.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2940</xocs:filesize>
               <xocs:pixel-height>80</xocs:pixel-height>
               <xocs:pixel-width>125</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0043135405002940-gr2.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0043135405002940/gr2/DOWNSAMPLED/image/jpeg/e86a491f5ce918fc088219e58b8f4659/gr2.jpg</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0043135405002940/gr2/DOWNSAMPLED/image/jpeg/e86a491f5ce918fc088219e58b8f4659/gr2.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr2</xocs:file-basename>
               <xocs:filename>gr2.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>24087</xocs:filesize>
               <xocs:pixel-height>243</xocs:pixel-height>
               <xocs:pixel-width>333</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0043135405002940-gr2.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0043135405002940/gr2/THUMBNAIL/image/gif/72c87da71d9c8e18fc313b2670f2f58c/gr2.sml</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0043135405002940/gr2/THUMBNAIL/image/gif/72c87da71d9c8e18fc313b2670f2f58c/gr2.sml</xocs:ucs-locator>
               <xocs:file-basename>gr2</xocs:file-basename>
               <xocs:filename>gr2.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2425</xocs:filesize>
               <xocs:pixel-height>91</xocs:pixel-height>
               <xocs:pixel-width>125</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0043135405002940-gr7.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0043135405002940/gr7/DOWNSAMPLED/image/jpeg/3d5612f05092140ffb00ed344a57efd2/gr7.jpg</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0043135405002940/gr7/DOWNSAMPLED/image/jpeg/3d5612f05092140ffb00ed344a57efd2/gr7.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr7</xocs:file-basename>
               <xocs:filename>gr7.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>23843</xocs:filesize>
               <xocs:pixel-height>223</xocs:pixel-height>
               <xocs:pixel-width>332</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0043135405002940-gr7.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0043135405002940/gr7/THUMBNAIL/image/gif/48b91b58325d61e1980677bcacc2b953/gr7.sml</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0043135405002940/gr7/THUMBNAIL/image/gif/48b91b58325d61e1980677bcacc2b953/gr7.sml</xocs:ucs-locator>
               <xocs:file-basename>gr7</xocs:file-basename>
               <xocs:filename>gr7.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2450</xocs:filesize>
               <xocs:pixel-height>84</xocs:pixel-height>
               <xocs:pixel-width>125</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0043135405002940-gr5.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0043135405002940/gr5/DOWNSAMPLED/image/jpeg/c4657a126217713f33e9fa94bc3fa7e8/gr5.jpg</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0043135405002940/gr5/DOWNSAMPLED/image/jpeg/c4657a126217713f33e9fa94bc3fa7e8/gr5.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr5</xocs:file-basename>
               <xocs:filename>gr5.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>24923</xocs:filesize>
               <xocs:pixel-height>198</xocs:pixel-height>
               <xocs:pixel-width>332</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0043135405002940-gr5.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0043135405002940/gr5/THUMBNAIL/image/gif/45fdbcb7604c7caf10799ae522a0087e/gr5.sml</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0043135405002940/gr5/THUMBNAIL/image/gif/45fdbcb7604c7caf10799ae522a0087e/gr5.sml</xocs:ucs-locator>
               <xocs:file-basename>gr5</xocs:file-basename>
               <xocs:filename>gr5.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2648</xocs:filesize>
               <xocs:pixel-height>74</xocs:pixel-height>
               <xocs:pixel-width>125</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0043135405002940-gr8.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0043135405002940/gr8/DOWNSAMPLED/image/jpeg/2b828269ff12be74363eb2889b4b60d5/gr8.jpg</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0043135405002940/gr8/DOWNSAMPLED/image/jpeg/2b828269ff12be74363eb2889b4b60d5/gr8.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr8</xocs:file-basename>
               <xocs:filename>gr8.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>63723</xocs:filesize>
               <xocs:pixel-height>533</xocs:pixel-height>
               <xocs:pixel-width>332</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0043135405002940-gr8.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0043135405002940/gr8/THUMBNAIL/image/gif/2ca42ff613b2cb2e7d15a5771cefa05d/gr8.sml</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0043135405002940/gr8/THUMBNAIL/image/gif/2ca42ff613b2cb2e7d15a5771cefa05d/gr8.sml</xocs:ucs-locator>
               <xocs:file-basename>gr8</xocs:file-basename>
               <xocs:filename>gr8.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2457</xocs:filesize>
               <xocs:pixel-height>93</xocs:pixel-height>
               <xocs:pixel-width>58</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
         </xocs:attachments>
      </xocs:attachment-metadata-doc>
   </xocs:meta><xocs:serial-item xmlns:xoe="http://www.elsevier.com/xml/xoe/dtd">
      <article xmlns="http://www.elsevier.com/xml/ja/dtd" docsubtype="fla" xml:lang="en" version="5.0">
         <item-info>
            <jid>WR</jid>
            <aid>5408</aid>
            <ce:pii>S0043-1354(05)00294-0</ce:pii>
            <ce:doi>10.1016/j.watres.2005.05.040</ce:doi>
            <ce:copyright type="full-transfer" year="2005">Elsevier Ltd</ce:copyright>
         </item-info>
         <ce:floats>
            <ce:figure id="fig1">
               <ce:label>Fig. 1</ce:label>
               <ce:caption>
                  <ce:simple-para view="all">Chemical structures of reactive pharmaceuticals and sites of proposed ClO<ce:inf loc="post">2</ce:inf> attack.</ce:simple-para>
               </ce:caption>
               <ce:link locator="gr1"/>
            </ce:figure>
            <ce:figure id="fig2">
               <ce:label>Fig. 2</ce:label>
               <ce:caption>
                  <ce:simple-para view="all">Apparent second-order rate constants and half-lives of the 4 reactive pharmaceuticals as a function of pH. The half-lives are calculated for a ClO<ce:inf loc="post">2</ce:inf> concentration of 0.1<ce:hsp sp="0.16"/>mg<ce:hsp sp="0.16"/>L<ce:sup loc="post">−1</ce:sup> (1.5<ce:hsp sp="0.16"/>μM).</ce:simple-para>
               </ce:caption>
               <ce:link locator="gr2"/>
            </ce:figure>
            <ce:figure id="fig3">
               <ce:label>Fig 3</ce:label>
               <ce:caption>
                  <ce:simple-para view="all">Relative residual concentrations of pharmaceuticals in drinking water after 30<ce:hsp sp="0.16"/>min of treatment at ClO<ce:inf loc="post">2</ce:inf> doses of 0.95 and 11.5<ce:hsp sp="0.16"/>mg<ce:hsp sp="0.16"/>L<ce:sup loc="post">−1</ce:sup>. The pharmaceuticals were spiked to the drinking water at a level of 1<ce:hsp sp="0.16"/>μg<ce:hsp sp="0.16"/>L<ce:sup loc="post">−1</ce:sup> before the experiments.</ce:simple-para>
               </ce:caption>
               <ce:link locator="gr3"/>
            </ce:figure>
            <ce:figure id="fig4">
               <ce:label>Fig. 4</ce:label>
               <ce:caption>
                  <ce:simple-para view="all">Oxidation of sulfamethoxazole and diclofenac during treatment of Lake Zurich water with ClO<ce:inf loc="post">2</ce:inf>. Experimental conditions: <mml:math altimg="si10.gif" overflow="scroll">
                        <mml:mrow>
                           <mml:mrow>
                              <mml:mi mathvariant="normal">pH</mml:mi>
                           </mml:mrow>
                           <mml:mo>=</mml:mo>
                           <mml:mn>8</mml:mn>
                        </mml:mrow>
                     </mml:math>, <mml:math altimg="si11.gif" overflow="scroll">
                        <mml:mrow>
                           <mml:mi>T</mml:mi>
                           <mml:mo>=</mml:mo>
                           <mml:mn>20</mml:mn>
                           <mml:mspace width=".16em"/>
                           <mml:mo>°</mml:mo>
                           <mml:mrow>
                              <mml:mi mathvariant="normal">C</mml:mi>
                           </mml:mrow>
                        </mml:mrow>
                     </mml:math>, ClO<ce:inf loc="post">2</ce:inf> dose=0.5<ce:hsp sp="0.16"/>mg L<ce:sup loc="post">−1</ce:sup>. Symbols represent measured data, and solid lines represent model calculations.</ce:simple-para>
               </ce:caption>
               <ce:link locator="gr4"/>
            </ce:figure>
            <ce:figure id="fig5">
               <ce:label>Fig 5</ce:label>
               <ce:caption>
                  <ce:simple-para view="all">Relative residual concentrations of selected pharmaceuticals after treatment of lake water with different ClO<ce:inf loc="post">2</ce:inf> doses. Experimental conditions: <mml:math altimg="si12.gif" overflow="scroll">
                        <mml:mrow>
                           <mml:mrow>
                              <mml:mi mathvariant="normal">pH</mml:mi>
                           </mml:mrow>
                           <mml:mo>=</mml:mo>
                           <mml:mn>8</mml:mn>
                        </mml:mrow>
                     </mml:math>, <mml:math altimg="si13.gif" overflow="scroll">
                        <mml:mrow>
                           <mml:mi>T</mml:mi>
                           <mml:mo>=</mml:mo>
                           <mml:mn>20</mml:mn>
                           <mml:mspace width=".16em"/>
                           <mml:mo>°</mml:mo>
                           <mml:mrow>
                              <mml:mi mathvariant="normal">C</mml:mi>
                           </mml:mrow>
                        </mml:mrow>
                     </mml:math>, [pharmaceuticals]<ce:inf loc="post">0</ce:inf>=0.3<ce:hsp sp="0.16"/>μM, contact time=10<ce:hsp sp="0.16"/>min.</ce:simple-para>
               </ce:caption>
               <ce:link locator="gr5"/>
            </ce:figure>
            <ce:figure id="fig6">
               <ce:label>Fig. 6</ce:label>
               <ce:caption>
                  <ce:simple-para view="all">Relative residual concentrations of selected sulfonamides, macrolides and estrogens in groundwater (Dübendorf, Switzerland) as a function of contact time with ClO<ce:inf loc="post">2</ce:inf>. Experimental conditions: ClO<ce:inf loc="post">2</ce:inf> dose=0.1<ce:hsp sp="0.16"/>mg<ce:hsp sp="0.16"/>L<ce:sup loc="post">−1</ce:sup>, <mml:math altimg="si14.gif" overflow="scroll">
                        <mml:mrow>
                           <mml:mrow>
                              <mml:mi mathvariant="normal">pH</mml:mi>
                           </mml:mrow>
                           <mml:mo>=</mml:mo>
                           <mml:mn>7.5</mml:mn>
                        </mml:mrow>
                     </mml:math>, <mml:math altimg="si15.gif" overflow="scroll">
                        <mml:mrow>
                           <mml:mi>T</mml:mi>
                           <mml:mo>=</mml:mo>
                           <mml:mn>20</mml:mn>
                           <mml:mspace width=".16em"/>
                           <mml:mo>°</mml:mo>
                           <mml:mrow>
                              <mml:mi mathvariant="normal">C</mml:mi>
                           </mml:mrow>
                        </mml:mrow>
                     </mml:math>, [sulfonamides]<ce:inf loc="post">0</ce:inf> and [estrogens]<ce:inf loc="post">0</ce:inf>=1<ce:hsp sp="0.16"/>μg<ce:hsp sp="0.16"/>L<ce:sup loc="post">−1</ce:sup>, [macrolides]<ce:inf loc="post">0</ce:inf>=100<ce:hsp sp="0.16"/>ng<ce:hsp sp="0.16"/>L<ce:sup loc="post">−1</ce:sup>.</ce:simple-para>
               </ce:caption>
               <ce:link locator="gr6"/>
            </ce:figure>
            <ce:figure id="fig7">
               <ce:label>Fig. 7</ce:label>
               <ce:caption>
                  <ce:simple-para view="all">Relative residual concentrations of roxithromycin for treatment of groundwater with a 0.1<ce:hsp sp="0.16"/>mg<ce:hsp sp="0.16"/>L<ce:sup loc="post">−1</ce:sup> ClO<ce:inf loc="post">2</ce:inf> dose. Experimental conditions: <mml:math altimg="si16.gif" overflow="scroll">
                        <mml:mrow>
                           <mml:mrow>
                              <mml:mi mathvariant="normal">pH</mml:mi>
                           </mml:mrow>
                           <mml:mo>=</mml:mo>
                           <mml:mn>7.5</mml:mn>
                        </mml:mrow>
                     </mml:math>, <mml:math altimg="si17.gif" overflow="scroll">
                        <mml:mrow>
                           <mml:mi>T</mml:mi>
                           <mml:mo>=</mml:mo>
                           <mml:mn>20</mml:mn>
                           <mml:mspace width=".16em"/>
                           <mml:mo>°</mml:mo>
                           <mml:mrow>
                              <mml:mi mathvariant="normal">C</mml:mi>
                           </mml:mrow>
                        </mml:mrow>
                     </mml:math>, [roxithromycin]<ce:inf loc="post">0</ce:inf>=100<ce:hsp sp="0.16"/>ng<ce:hsp sp="0.16"/>L<ce:sup loc="post">−1</ce:sup> (0.3<ce:hsp sp="0.16"/>μM), [sulfamethoxazole]<ce:inf loc="post">0</ce:inf>=1<ce:hsp sp="0.16"/>μg<ce:hsp sp="0.16"/>L<ce:sup loc="post">−1</ce:sup> (0.3<ce:hsp sp="0.16"/>μM). Symbols represent measured data, solid lines represent model calculations, and dashed lines indicate the estimated uncertainty of the model calculations.</ce:simple-para>
               </ce:caption>
               <ce:link locator="gr7"/>
            </ce:figure>
            <ce:figure id="fig8">
               <ce:label>Fig. 8</ce:label>
               <ce:caption>
                  <ce:simple-para view="all">Comparison of apparent second-order rate constants for the reaction of selected pharmaceuticals with ozone, chlorine dioxide and chlorine at pH 7. The column on the right-hand side presents theoretical half-lives calculated for an oxidant concentration of 1<ce:hsp sp="0.16"/>mg<ce:hsp sp="0.16"/>L<ce:sup loc="post">−1</ce:sup>. For ozone, only the direct reactions with O<ce:inf loc="post">3</ce:inf> were considered (neglecting hydroxyl radicals). Unavailable rate constants are designated with n.d. for not determined. For the reaction of naproxen with ClO<ce:inf loc="post">2</ce:inf> only a range for <ce:italic>k</ce:italic>
                     <ce:inf loc="post">app</ce:inf> can be given. Sources for rate constants not determined in the present study: <ce:cross-ref refid="bib11">Huber et al. (2003)</ce:cross-ref>, <ce:cross-ref refid="bib5">Deborde et al. (2004)</ce:cross-ref>, <ce:cross-ref refid="bib6">Dodd and Huang (2004)</ce:cross-ref>, <ce:cross-ref refid="bib18">Pinkston and Sedlak (2004)</ce:cross-ref>.</ce:simple-para>
               </ce:caption>
               <ce:link locator="gr8"/>
            </ce:figure>
            <ce:table xmlns="http://www.elsevier.com/xml/common/cals/dtd" id="tbl1" frame="topbot" rowsep="0" colsep="0">
               <ce:label>Table 1</ce:label>
               <ce:caption>
                  <ce:simple-para view="all">Investigated pharmaceuticals</ce:simple-para>
               </ce:caption>
               <tgroup cols="3">
                  <colspec colnum="1" colname="col1"/>
                  <colspec colnum="2" colname="col2"/>
                  <colspec colnum="3" colname="col3"/>
                  <thead>
                     <row rowsep="1" valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Name</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">CAS RN</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Use/Origin</entry>
                     </row>
                  </thead>
                  <tbody>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <italic>Antibiotics</italic>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd"/>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Azithromycin</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">83905-01-5</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Macrolide antibiotic</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Clarithromycin</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">81103-11-9</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Macrolide antibiotic</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Dehydro-erythromycin</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Metabolite erythromycin</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Roxithromycin</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">80214-83-1</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Macrolide antibiotic</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Sulfamethazine</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">57-68-1</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Sulfonamide antibiotic</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Sulfamethoxazole</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">723-46-6</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Sulfonamide antibiotic</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Sulfapyridine</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">144-83-2</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Sulfonamide antibiotic</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Sulfathiazole</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">72-14-0</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Sulfonamide antibiotic<vsp sp="1.0"/>
                        </entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <italic>Estrogens</italic>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd"/>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">17<italic>α</italic>-ethinylestradiol (EE2)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">57-63-6</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Synthetic steroid hormone</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">17<italic>β</italic>-estradiol</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">50-28-2</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Natural steroid hormone</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Estrone</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">53-16-7</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Natural steroid hormone<vsp sp="1.0"/>
                        </entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <italic>Acidic pharmaceuticals</italic>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd"/>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Bezafibrate</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">41859-67-0</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Lipid regulator</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Clofibric acid</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">882-09-7</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Metabolite of several lipid regulators</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Diclofenac</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">15307-86-5</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Antiphlogistic</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Fenoprofen</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">53746-45-5</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Antiphlogistic</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Gemifibrozil</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">25812-30-0</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Lipid regulator</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Ibuprofen</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">15687-27-1</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Antiphlogistic</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Ketoprofen</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">22071-15-4</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Antiphlogistic</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Naproxen</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">22204-53-1</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Antiphlogistic<vsp sp="1.0"/>
                        </entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <italic>Neutral pharmaceuticals</italic>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd"/>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Caffeine</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">58-08-2</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Psychostimulant</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Carbamazepine</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">298-46-4</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Antiepileptic drug</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Cyclophosphamide</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">6055-19-2</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Antineoplastic</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Diazepam</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">439-14-5</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Psychiatric drug</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Dimethylaminophenazone</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">58-15-1</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Antiphlogistic</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Glibenclamide</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">10238-21-8</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Antidiabetic</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Ifosfamide</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">3778-73-2</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Antineoplastic</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Pentoxifylline</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">6493-05-6</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Vasodilator</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Phenazone</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">60-80-0</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Antiphlogistic</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Propylphenazone</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">479-92-5</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Antiphlogistic<vsp sp="1.0"/>
                        </entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <italic>X-ray contrast media</italic>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd"/>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Iopromide</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">73334-07-3</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Contrast medium</entry>
                     </row>
                  </tbody>
               </tgroup>
            </ce:table>
            <ce:table xmlns="http://www.elsevier.com/xml/common/cals/dtd" id="tbl2" frame="topbot" rowsep="0" colsep="0">
               <ce:label>Table 2</ce:label>
               <ce:caption>
                  <ce:simple-para view="all">Water quality parameters</ce:simple-para>
               </ce:caption>
               <tgroup cols="5">
                  <colspec colnum="1" colname="col1"/>
                  <colspec colnum="2" colname="col2"/>
                  <colspec colnum="3" colname="col3"/>
                  <colspec colnum="4" colname="col4"/>
                  <colspec colnum="5" colname="col5"/>
                  <thead>
                     <row rowsep="1" valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">pH</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">DOC (mg<hsp sp="0.16"/>L<sup loc="post">−1</sup>)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">ClO<inf loc="post">2</inf> demand<cross-ref refid="tblfn2a">
                              <sup loc="post">a</sup>
                           </cross-ref> (mg/L)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Alkalinity (mM HCO<inf loc="post">3</inf>
                           <sup loc="post">−</sup>)</entry>
                     </row>
                  </thead>
                  <tbody>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Drinking water, Germany</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">7.4</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">1.0</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">n.d.</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">4.4</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Water source: bank filtrate River Rhine</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char="."/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char="."/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char="."/>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Lake water, Zurich, Switzerland</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">7.9</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">1.6</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">∼0.2</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">2.5</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Groundwater, Duebendorf, Switzerland</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">7.2</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">1.3</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">∼0.08</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">6.6</entry>
                     </row>
                  </tbody>
               </tgroup>
               <ce:legend>
                  <ce:simple-para view="all">n.d. not determined.</ce:simple-para>
               </ce:legend>
               <ce:table-footnote id="tblfn2a">
                  <ce:label>a</ce:label>
                  <ce:note-para>ClO<ce:inf loc="post">2</ce:inf> consumed within 1<ce:hsp sp="0.16"/>h for an initial dose of 0.5<ce:hsp sp="0.16"/>mg/L in lake water and 0.1<ce:hsp sp="0.16"/>mg/L in groundwater.</ce:note-para>
               </ce:table-footnote>
            </ce:table>
            <ce:table xmlns="http://www.elsevier.com/xml/common/cals/dtd" id="tbl3" frame="topbot" rowsep="0" colsep="0">
               <ce:label>Table 3</ce:label>
               <ce:caption>
                  <ce:simple-para view="all">Second-order rate constants for the reaction of chlorine dioxide with selected pharmaceuticals</ce:simple-para>
               </ce:caption>
               <tgroup cols="5">
                  <colspec colnum="1" colname="col1"/>
                  <colspec colnum="2" colname="col2"/>
                  <colspec colnum="3" colname="col3"/>
                  <colspec colnum="4" colname="col4"/>
                  <colspec colnum="5" colname="col5"/>
                  <thead>
                     <row rowsep="1" valign="bottom">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Compound (species)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">p<italic>K</italic>
                           <inf loc="post">a</inf>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <mml:math altimg="si18.gif" overflow="scroll">
                              <mml:mrow>
                                 <mml:msub>
                                    <mml:mrow>
                                       <mml:mi>k</mml:mi>
                                    </mml:mrow>
                                    <mml:mrow>
                                       <mml:mrow>
                                          <mml:msub>
                                             <mml:mrow>
                                                <mml:mrow>
                                                   <mml:mi mathvariant="normal">ClO</mml:mi>
                                                </mml:mrow>
                                             </mml:mrow>
                                             <mml:mrow>
                                                <mml:mn>2</mml:mn>
                                             </mml:mrow>
                                          </mml:msub>
                                       </mml:mrow>
                                    </mml:mrow>
                                 </mml:msub>
                              </mml:mrow>
                           </mml:math>(M<sup loc="post">−1</sup> s<sup loc="post">−1</sup>)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <italic>t</italic>
                           <inf loc="post">1/2</inf> for 0.1<hsp sp="0.16"/>mg ClO<inf loc="post">2</inf> at pH 7</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Studied pH range</entry>
                     </row>
                  </thead>
                  <tbody>
                     <row valign="bottom">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Bezafibrate (anion)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">3.6</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">&lt;0.01</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">7</entry>
                     </row>
                     <row valign="bottom">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Carbamazepine (neutral)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">&lt;0.015</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">7</entry>
                     </row>
                     <row valign="bottom">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Diazepam (neutral)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">&lt;0.025</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">7</entry>
                     </row>
                     <row valign="bottom">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Diclofenac (anion)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">4.2</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">(1.05±0.1)×10<sup loc="post">4</sup>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">45<hsp sp="0.16"/>s</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">5–10</entry>
                     </row>
                     <row valign="bottom">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">EE2 (neutral)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">10.4</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">&lt;200</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">2–3</entry>
                     </row>
                     <row valign="bottom">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">EE2 (anion)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">(4.6±0.8)×10<sup loc="post">8</sup>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">2.5<hsp sp="0.16"/>s</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">4–6</entry>
                     </row>
                     <row valign="bottom">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Ibuprofen (anion)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">4.9</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">&lt;0.01</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">7</entry>
                     </row>
                     <row valign="bottom">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Iopromide (neutral)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">&lt;0.01</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">7</entry>
                     </row>
                     <row valign="bottom">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Roxithromycin (neutral)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">8.8</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">(1.4±0.3)×10<sup loc="post">4</sup>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">35<hsp sp="0.16"/>min</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">6–7</entry>
                     </row>
                     <row valign="bottom">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Sulfamethoxazole (neutral)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">5.7</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">&lt;100</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">4</entry>
                     </row>
                     <row valign="bottom">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Sulfamethoxazole (anion)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">(7.9±0.9)×10<sup loc="post">3</sup>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">70<hsp sp="0.16"/>s</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">5–10</entry>
                     </row>
                  </tbody>
               </tgroup>
            </ce:table>
            <ce:table xmlns="http://www.elsevier.com/xml/common/cals/dtd" id="tbl4" frame="topbot" rowsep="0" colsep="0">
               <ce:label>Table 4</ce:label>
               <ce:caption>
                  <ce:simple-para view="all">Relative residual concentrations (C/C<ce:inf loc="post">0</ce:inf>) of selected pharmaceuticals after 30<ce:hsp sp="0.16"/>min treatment of drinking water spiked with 0.95 and 11.5<ce:hsp sp="0.16"/>mg<ce:hsp sp="0.16"/>L<ce:sup loc="post">−1</ce:sup> ClO<ce:inf loc="post">2</ce:inf> and estimated second-order rate constants</ce:simple-para>
               </ce:caption>
               <tgroup cols="4">
                  <colspec colnum="1" colname="col1"/>
                  <colspec colnum="2" colname="col2"/>
                  <colspec colnum="3" colname="col3"/>
                  <colspec colnum="4" colname="col4"/>
                  <thead>
                     <row rowsep="1">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="bottom">Compound (species)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="top">0.95<hsp sp="0.16"/>mg<hsp sp="0.16"/>L<sup loc="post">−1</sup> ClO<inf loc="post">2</inf> C/C<inf loc="post">0</inf> (%)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="bottom">11.5<hsp sp="0.16"/>mg<hsp sp="0.16"/>L<sup loc="post">−1</sup> ClO<inf loc="post">2</inf> C/C<inf loc="post">0</inf> (%)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="bottom">Estimated <mml:math altimg="si19.gif" overflow="scroll">
                              <mml:mrow>
                                 <mml:msub>
                                    <mml:mrow>
                                       <mml:mi>k</mml:mi>
                                    </mml:mrow>
                                    <mml:mrow>
                                       <mml:mrow>
                                          <mml:msub>
                                             <mml:mrow>
                                                <mml:mrow>
                                                   <mml:mi mathvariant="normal">ClO</mml:mi>
                                                </mml:mrow>
                                             </mml:mrow>
                                             <mml:mrow>
                                                <mml:mn>2</mml:mn>
                                             </mml:mrow>
                                          </mml:msub>
                                       </mml:mrow>
                                    </mml:mrow>
                                 </mml:msub>
                              </mml:mrow>
                           </mml:math> (M<sup loc="post">−1</sup> s<sup loc="post">−1</sup> )</entry>
                     </row>
                  </thead>
                  <tbody>
                     <row>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="bottom">Caffeine</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="top">100 (±12)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="top">99 (±7)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="bottom">&lt;1</entry>
                     </row>
                     <row>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="bottom">Clofibric acid</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="top">100 (±9)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="top">100 (±5)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="bottom">&lt;1</entry>
                     </row>
                     <row>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="bottom">Cyclophosphamide</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="top">97 (±3)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="top">88 (±13)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="bottom">&lt;1</entry>
                     </row>
                     <row>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="bottom">Fenoprofen</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="top">103 (±23)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="top">103 (±30)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="bottom">&lt;1</entry>
                     </row>
                     <row>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="bottom">Gemifibrozil</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="top">93 (±10)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="top">59 (±6)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="bottom">&lt;10</entry>
                     </row>
                     <row>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="bottom">Glibenclamide</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="top">86 (±14)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="top">71 (±8)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="bottom">&lt;10</entry>
                     </row>
                     <row>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="bottom">Ifosfamide</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="top">98 (±1)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="top">97 (±6)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="bottom">&lt;1</entry>
                     </row>
                     <row>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="bottom">Ketoprofen</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="top">105 (±12)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="top">99 (±3)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="bottom">&lt;1</entry>
                     </row>
                     <row>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="bottom">Naproxen</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="top">53 (±9)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="top">—</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="bottom">10–100</entry>
                     </row>
                     <row>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="bottom">Pentoxifylline</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="top">98 (±4)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="top">102 (±12)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="bottom">&lt;1</entry>
                     </row>
                     <row>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="bottom">Phenazone</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="top">&lt; LOQ</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="top">&lt; LOQ</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="bottom">&gt;100</entry>
                     </row>
                     <row>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="bottom">Dimethylaminophenazone</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="top">&lt; LOQ</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="bottom">&lt; LOQ</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="bottom">&gt;100</entry>
                     </row>
                     <row>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="bottom">Propylphenazone</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="top">&lt; LOQ</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="top">&lt; LOQ</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" valign="bottom">&gt;100</entry>
                     </row>
                  </tbody>
               </tgroup>
               <ce:legend>
                  <ce:simple-para view="all">Experimental conditions: pH=7.4, T=20<ce:hsp sp="0.16"/>°C, contact time=30<ce:hsp sp="0.16"/>min, LOQ: limit of quantification.</ce:simple-para>
               </ce:legend>
            </ce:table>
         </ce:floats>
         <head>
            <ce:title>Oxidation of pharmaceuticals during water treatment with chlorine dioxide</ce:title>
            <ce:author-group>
               <ce:author>
                  <ce:given-name>Marc M.</ce:given-name>
                  <ce:surname>Huber</ce:surname>
                  <ce:cross-ref refid="aff1">
                     <ce:sup loc="post">a</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:author>
                  <ce:given-name>Susanna</ce:given-name>
                  <ce:surname>Korhonen</ce:surname>
                  <ce:cross-ref refid="aff2">
                     <ce:sup loc="post">b</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:author>
                  <ce:given-name>Thomas A.</ce:given-name>
                  <ce:surname>Ternes</ce:surname>
                  <ce:cross-ref refid="aff3">
                     <ce:sup loc="post">c</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:author>
                  <ce:initials>Urs</ce:initials>
                  <ce:given-name>Urs</ce:given-name>
                  <ce:surname>von Gunten</ce:surname>
                  <ce:cross-ref refid="aff1">
                     <ce:sup loc="post">a</ce:sup>
                  </ce:cross-ref>
                  <ce:cross-ref refid="cor1">
                     <ce:sup loc="post">⁎</ce:sup>
                  </ce:cross-ref>
                  
               </ce:author>
               <ce:affiliation id="aff1">
                  <ce:label>a</ce:label>
                  <ce:textfn>Swiss Federal Institute of Aquatic Science and Technology (EAWAG), Ueberlandstrasse 133, CH-8600 Duebendorf, Switzerland</ce:textfn>
               </ce:affiliation>
               <ce:affiliation id="aff2">
                  <ce:label>b</ce:label>
                  <ce:textfn>Helsinki University of Technology, Otaniemi International Innovation Centre, P.O. Box 9202, FIN-02015 HUT, Finland</ce:textfn>
               </ce:affiliation>
               <ce:affiliation id="aff3">
                  <ce:label>c</ce:label>
                  <ce:textfn>Federal Institute of Hydrology (BfG), Am Mainzer Tor 1, D-56068 Koblenz, Germany</ce:textfn>
               </ce:affiliation>
               <ce:correspondence id="cor1">
                  <ce:label>⁎</ce:label>
                  <ce:text>Corresponding author. Tel.: +41<ce:hsp sp="0.16"/>44<ce:hsp sp="0.16"/>8235270; fax: +41<ce:hsp sp="0.16"/>44<ce:hsp sp="0.16"/>8235210.</ce:text>
               </ce:correspondence>
            </ce:author-group>
            <ce:date-received day="3" month="11" year="2004"/>
            <ce:date-revised day="1" month="5" year="2005"/>
            <ce:date-accepted day="25" month="5" year="2005"/>
            <ce:abstract class="author"><ce:abstract-sec>
                  <ce:simple-para view="all">The potential of chlorine dioxide (ClO<ce:inf loc="post">2</ce:inf>) for the oxidation of pharmaceuticals during water treatment was assessed by determining second-order rate constants for the reaction with selected environmentally relevant pharmaceuticals. Out of 9 pharmaceuticals only the 4 following compounds showed an appreciable reactivity with ClO<ce:inf loc="post">2</ce:inf> (in brackets apparent second-order rate constants at pH 7 and <mml:math altimg="si6.gif" overflow="scroll">
                        <mml:mrow>
                           <mml:mi>T</mml:mi>
                           <mml:mo>=</mml:mo>
                           <mml:mn>20</mml:mn>
                           <mml:mspace width=".16em"/>
                           <mml:mo>°</mml:mo>
                           <mml:mrow>
                              <mml:mi mathvariant="normal">C</mml:mi>
                           </mml:mrow>
                        </mml:mrow>
                     </mml:math>): the sulfonamide antibiotic sulfamethoxazole (6.7×10<ce:sup loc="post">3</ce:sup>
                     <ce:hsp sp="0.16"/>M<ce:sup loc="post">−1</ce:sup>
                     <ce:hsp sp="0.16"/>s<ce:sup loc="post">−1</ce:sup>), the macrolide antibiotic roxithromycin (2.2×10<ce:sup loc="post">2</ce:sup>
                     <ce:hsp sp="0.16"/>M<ce:sup loc="post">−1</ce:sup>
                     <ce:hsp sp="0.16"/>s<ce:sup loc="post">−1</ce:sup>), the estrogen 17<ce:italic>α</ce:italic>-ethinylestradiol (∼2×10<ce:sup loc="post">5</ce:sup>
                     <ce:hsp sp="0.16"/>M<ce:sup loc="post">−1</ce:sup>
                     <ce:hsp sp="0.16"/>s<ce:sup loc="post">−1</ce:sup>), and the antiphlogistic diclofenac (1.05×10<ce:sup loc="post">4</ce:sup>
                     <ce:hsp sp="0.16"/>M<ce:sup loc="post">−1</ce:sup>
                     <ce:hsp sp="0.16"/>s<ce:sup loc="post">−1</ce:sup>). Experiments performed using natural water showed that ClO<ce:inf loc="post">2</ce:inf> also reacted fast with other sulfonamides and macrolides, the natural hormones estrone and 17<ce:italic>β</ce:italic>-estradiol as well as 3 pyrazolone derivatives (phenazone, propylphenazone, and dimethylaminophenazone). However, many compounds in the study were ClO<ce:inf loc="post">2</ce:inf> refractive. Experiments with lake water and groundwater that were partly performed at microgram/L to nanogram/L levels proved that the rate constants determined in pure water could be applied to predict the oxidation of pharmaceuticals in natural waters. Compared to ozone, ClO<ce:inf loc="post">2</ce:inf> reacted more slowly and with fewer compounds. However, it reacted faster with the investigated compounds than chlorine. Overall, the results indicate that ClO<ce:inf loc="post">2</ce:inf> will only be effective to oxidize certain compound classes such as the investigated classes of sulfonamide and macrolide antibiotics, and estrogens.</ce:simple-para>
               </ce:abstract-sec></ce:abstract>
            <ce:keywords class="keyword">
               <ce:section-title>Keywords</ce:section-title>
               <ce:keyword>
                  <ce:text>Water treatment</ce:text>
               </ce:keyword>
               <ce:keyword>
                  <ce:text>Chlorine dioxide</ce:text>
               </ce:keyword>
               <ce:keyword>
                  <ce:text>Pharmaceuticals</ce:text>
               </ce:keyword>
               <ce:keyword>
                  <ce:text>Rate constants</ce:text>
               </ce:keyword>
               <ce:keyword>
                  <ce:text>Antibiotics</ce:text>
               </ce:keyword>
               <ce:keyword>
                  <ce:text>Estrogens</ce:text>
               </ce:keyword>
            </ce:keywords>
         </head>
         <body view="all">
            <ce:sections>
               <ce:section view="all">
                  <ce:label>1</ce:label>
                  <ce:section-title>Introduction</ce:section-title>
                  <ce:section view="all">
                     <ce:label>1.1</ce:label>
                     <ce:section-title>Pharmaceuticals in the environment</ce:section-title>
                     <ce:para view="all">The widespread occurrence of a large number of pharmaceuticals in the aquatic environment (<ce:cross-ref refid="bib26">Ternes, 1998</ce:cross-ref>; <ce:cross-ref refid="bib13">Kolpin et al., 2002</ce:cross-ref>) may threaten the purity of drinking water. Because surface water is the most affected, pharmaceuticals may first pose a problem to utilities that use surface water as a source for drinking water production. However, studies on different treatment processes including ozonation (<ce:cross-ref refid="bib11">Huber et al., 2003</ce:cross-ref>; <ce:cross-ref refid="bib30">Ternes et al., 2002</ce:cross-ref>), activated carbon (<ce:cross-ref refid="bib30">Ternes et al., 2002</ce:cross-ref>; <ce:cross-ref refid="bib19">Poseidon Report, 2004</ce:cross-ref>), and nanofiltration/reverse osmosis membranes (<ce:cross-ref refid="bib19">Poseidon Report, 2004</ce:cross-ref>) have lately demonstrated that these processes can efficiently remove a relatively large number of pharmaceuticals. In Europe, typical treatment trains for surface water include at least one of the above mentioned processes. Therefore, these findings suggest that at least in Europe only few pharmaceuticals will be present in treated surface water. The fact that pharmaceuticals were detected in relatively few cases in finished drinking water provides further support for this conclusion (<ce:cross-ref refid="bib30">Ternes et al., 2002</ce:cross-ref>; <ce:cross-ref refid="bib21">Reddersen et al., 2002</ce:cross-ref>; <ce:cross-ref refid="bib25">Stackelberg et al., 2004</ce:cross-ref>; <ce:cross-ref refid="bib33">Webb et al., 2003</ce:cross-ref>). However, pharmaceuticals were not only detected in surface waters, but also in groundwaters (<ce:cross-ref refid="bib23">Sacher et al., 2001</ce:cross-ref>; <ce:cross-ref refid="bib9">Hirsch et al., 1999</ce:cross-ref>; <ce:cross-ref refid="bib28">Ternes and Hirsch, 2000</ce:cross-ref>). Sources for groundwater contamination can be land application of sludge or manure contaminated with human or veterinary pharmaceuticals, river bank filtration of contaminated surface water into groundwater, and artificial groundwater recharge with contaminated water (<ce:cross-ref refid="bib27">Ternes, 2001</ce:cross-ref>). Groundwater does not usually require multiple treatment steps, because of its good chemical and biological quality. Often, it is only subjected to a disinfection step (e.g., treatment with chlorine, UV, or chlorine dioxide) or not treated at all. Consequently, there is a risk that pharmaceuticals could be present in drinking water derived from groundwater.</ce:para>
                  </ce:section>
                  <ce:section view="all">
                     <ce:label>1.2</ce:label>
                     <ce:section-title>Application of chlorine dioxide for water treatment</ce:section-title>
                     <ce:para view="all">Chlorine dioxide (ClO<ce:inf loc="post">2</ce:inf>) is an oxidant used for the disinfection of relatively high quality water, such as groundwater or treated surface water. Appropriate dosing of chlorine dioxide to treated water provides residual concentrations, which protect the drinking water distribution system from microbiological recontamination and fouling. In Europe, these ClO<ce:inf loc="post">2</ce:inf> residuals are often kept &lt;0.05–0.1<ce:hsp sp="0.16"/>mg<ce:hsp sp="0.16"/>L<ce:sup loc="post">−1</ce:sup> (<ce:cross-ref refid="bib7">Gates, 1998</ce:cross-ref>). In the USA, ClO<ce:inf loc="post">2</ce:inf> is mainly used for the preoxidation of surface water. ClO<ce:inf loc="post">2</ce:inf> dosages ranging from 1 to 1.4<ce:hsp sp="0.16"/>mg<ce:hsp sp="0.16"/>L<ce:sup loc="post">−1</ce:sup> (<ce:cross-ref refid="bib2">Chen and Regli, 2002</ce:cross-ref>; <ce:cross-ref refid="bib7">Gates, 1998</ce:cross-ref>) are common in this case because higher doses are likely to produce chlorite levels that exceed the USEPA chlorite standard of 1<ce:hsp sp="0.16"/>mg/L (<ce:cross-ref refid="bib31">USEPA, 1998</ce:cross-ref>). Chlorite is the major reduction product of chlorine dioxide. It is considered to be a blood poison (<ce:cross-ref refid="bib4">Condie, 1986</ce:cross-ref>). A further application of ClO<ce:inf loc="post">2</ce:inf> in water treatment is disinfection of wastewater. Compared to chlorine, the major advantages of ClO<ce:inf loc="post">2</ce:inf> are the more effective inactivation of protozoa (e.g., <ce:italic>Cryptosporidium</ce:italic> and <ce:italic>Giardia</ce:italic>) and the fact that halogenated disinfection by-products are not formed under proper generation conditions (<ce:cross-ref refid="bib32">USEPA, 1999</ce:cross-ref>).</ce:para>
                  </ce:section>
                  <ce:section view="all">
                     <ce:label>1.3</ce:label>
                     <ce:section-title>Chemical aspects of chlorine dioxide</ce:section-title>
                     <ce:para view="all">Chemically, ClO<ce:inf loc="post">2</ce:inf> is a stable free radical that reacts with other water matrix components and micropollutants mainly through a one electron transfer reaction. A comprehensive study on the kinetics of ClO<ce:inf loc="post">2</ce:inf> reactions in water has been published by <ce:cross-ref refid="bib10">Hoigné and Bader (1994)</ce:cross-ref>. They have shown that ClO<ce:inf loc="post">2</ce:inf> is a highly selective oxidant with respect to specific functional groups of organic compounds like phenolic moieties or tertiary amino groups. The reactivity of these moieties is governed by speciation, because the reactivity of the phenoxide ion and the neutral form of the amine is many orders of magnitude higher than the reactivity of the neutral phenol and the protonated amine.</ce:para>
                     <ce:para view="all">Many pharmaceuticals exhibit phenolic moieties and/or amino groups in their structure. Therefore, ClO<ce:inf loc="post">2</ce:inf> is expected to oxidize a relatively large number of pharmaceuticals, despite its lower oxidation potential compared to ozone and hypochlorous acid. Considering the current use of ClO<ce:inf loc="post">2</ce:inf> in Europe, it is important to know to what extent ClO<ce:inf loc="post">2</ce:inf> can act as a barrier for pharmaceuticals when disinfection is the only treatment step. Furthermore, ClO<ce:inf loc="post">2</ce:inf> should be compared to other oxidants such as ozone and chlorine to check whether it is as effective for the oxidation of pharmaceuticals when used for preoxidation of surface water or for the oxidation of wastewater.</ce:para>
                  </ce:section>
                  <ce:section view="all">
                     <ce:label>1.4</ce:label>
                     <ce:section-title>Objectives of the present study</ce:section-title>
                     <ce:para view="all">The aim of the present study was to assess the potential of ClO<ce:inf loc="post">2</ce:inf> to oxidize pharmaceuticals during water treatment. For this purpose, second-order rate constant of selected environmentally relevant pharmaceuticals were determined in bench-scale experiments using pure aqueous solutions. In addition, rate constants of further pharmaceuticals were estimated based on their oxidation in lab-scale experiments performed using drinking water. With experiments in surface water and groundwater at concentrations in the nanogram/L to microgram/L range the validity of the rate constants was verified. Finally, the rate constants were compared to rate constants available for ozone and chlorine.</ce:para>
                  </ce:section>
               </ce:section>
               <ce:section view="all">
                  <ce:label>2</ce:label>
                  <ce:section-title>Experimental methods</ce:section-title>
                  <ce:section view="all">
                     <ce:label>2.1</ce:label>
                     <ce:section-title>Chemicals</ce:section-title>
                     <ce:para view="all">Chlorine dioxide was produced by mixing 50<ce:hsp sp="0.16"/>mL of 4% potassium peroxodisulfate (K<ce:inf loc="post">2</ce:inf>S<ce:inf loc="post">2</ce:inf>O<ce:inf loc="post">8</ce:inf>, 2<ce:hsp sp="0.16"/>g in 50<ce:hsp sp="0.16"/>mL Milli-Q water) with 50<ce:hsp sp="0.16"/>mL of 8% sodium chlorite (NaClO<ce:inf loc="post">2</ce:inf>, 4<ce:hsp sp="0.16"/>g in 50<ce:hsp sp="0.16"/>mL Milli-Q water) according to a method described by <ce:cross-ref refid="bib7">Gates (1998)</ce:cross-ref>. Caution: ClO<ce:inf loc="post">2</ce:inf> present in the gas-phase equilibrated with an aqueous solution containing &gt;8<ce:hsp sp="0.16"/>g<ce:hsp sp="0.16"/>L<ce:sup loc="post">−1</ce:sup> of ClO<ce:inf loc="post">2</ce:inf> (&gt;20<ce:hsp sp="0.16"/>°C) is explosive. Pharmaceuticals were purchased from commercial suppliers at the purest grade available. All chemicals used for solutions (buffer, eluents, etc.) were reagent grade and were used without further purification. Stock solutions of pharmaceuticals were prepared either directly in Milli-Q water or in methanol.</ce:para>
                  </ce:section>
                  <ce:section view="all">
                     <ce:label>2.2</ce:label>
                     <ce:section-title>Analytical methods</ce:section-title>
                     <ce:para view="all">ClO<ce:inf loc="post">2</ce:inf> concentrations were determined using three different methods as a function of experimental setup and conditions: (1) The direct spectrophotometrical determination at 359<ce:hsp sp="0.16"/>nm using an absorption coefficient of <mml:math altimg="si7.gif" overflow="scroll">
                           <mml:mrow>
                              <mml:mi>ε</mml:mi>
                              <mml:mo>=</mml:mo>
                              <mml:mn>1200</mml:mn>
                              <mml:mspace width=".16em"/>
                              <mml:msup>
                                 <mml:mrow>
                                    <mml:mrow>
                                       <mml:mi mathvariant="normal">M</mml:mi>
                                    </mml:mrow>
                                 </mml:mrow>
                                 <mml:mrow>
                                    <mml:mo>-</mml:mo>
                                    <mml:mn>1</mml:mn>
                                 </mml:mrow>
                              </mml:msup>
                              <mml:mspace width=".16em"/>
                              <mml:msup>
                                 <mml:mrow>
                                    <mml:mrow>
                                       <mml:mi mathvariant="normal">cm</mml:mi>
                                    </mml:mrow>
                                 </mml:mrow>
                                 <mml:mrow>
                                    <mml:mo>-</mml:mo>
                                    <mml:mn>1</mml:mn>
                                 </mml:mrow>
                              </mml:msup>
                           </mml:mrow>
                        </mml:math> (<ce:cross-ref refid="bib10">Hoigné and Bader, 1994</ce:cross-ref>), (2) the ABTS method (using 2,2-azino-bis(3-ethylbenzothiazoline)-6-sulfonic acid-diammonium salt), a colorimetric method adapted from <ce:cross-ref refid="bib17">Pinkernell et al. (2000)</ce:cross-ref>, and (3) the LGB method, a colorimetric method using lissamine green B (<ce:cross-ref refid="bib3">Chiswell and O’Halloran, 1991</ce:cross-ref>). The latter method had to be applied because certain target compounds produced interferences with ABTS.</ce:para>
                     <ce:para view="all">For the determination of rate constants and experiments with water from Lake Zurich, sulfamethoxazole and diclofenac concentrations were measured with a Hewlett-Packard 1050 series HPLC equipped with an Ultra Aqueous C18 column from Restek (3.2×100<ce:hsp sp="0.16"/>mm, 5<ce:hsp sp="0.16"/>μm) and a variable wavelength detector. The eluents consisted of 10<ce:hsp sp="0.16"/>mM phosphoric acid (A) and pure acetonitrile (B). Isocratic elution at a flow rate of 0.5<ce:hsp sp="0.16"/>mL<ce:hsp sp="0.16"/>min<ce:sup loc="post">−1</ce:sup> was carried out using A:B=60%:40% and 25%:75% for diclofenac and sulfamethoxazole, respectively. With detection of diclofenac at 275<ce:hsp sp="0.16"/>nm and sulfamethoxazole at 267<ce:hsp sp="0.16"/>nm, a limit of quantification (LOQ) of approximately 20<ce:hsp sp="0.16"/>nM (5<ce:hsp sp="0.16"/>μg<ce:hsp sp="0.16"/>L<ce:sup loc="post">−1</ce:sup>) was achieved. The 95% confidence intervals for a single measurement were typically ±3–5%. With a similar method, 17<ce:italic>α</ce:italic>-ethinylestradiol (EE2) was detected using fluorescence detection as described in <ce:cross-ref refid="bib12">Huber et al. (2004)</ce:cross-ref>. The LOQ was 5<ce:hsp sp="0.16"/>nM (1.5<ce:hsp sp="0.16"/>μg<ce:hsp sp="0.16"/>L<ce:sup loc="post">−1</ce:sup>) for this method.</ce:para>
                     <ce:para view="all">For the analysis of trace concentrations of antibiotics in groundwater (for a list of compounds see <ce:cross-ref refid="tbl1">Table 1</ce:cross-ref>
                        <ce:float-anchor refid="tbl1"/>), aliquots of 500<ce:hsp sp="0.16"/>mL were adjusted to pH 4, and enriched unfiltered using solid phase extraction on Oasis HLB cartridges (<ce:cross-ref refid="bib8">Göbel et al., 2004</ce:cross-ref>). Measurement was conducted using reversed-phase liquid chromatography coupled to electrospray positive tandem mass spectrometry (TSQ Quantum Discovery, Thermo Finnigan, San Jose, CA, USA). Quantification was performed using a standard addition method. The selected estrogens (<ce:cross-ref refid="tbl1">Table 1</ce:cross-ref>) were extracted from 500<ce:hsp sp="0.16"/>mL samples at pH 3 with pre-packed Lichrolut EN/PR-C18 cartridges followed by a silica clean-up (<ce:cross-ref refid="bib24">Schönenberger and Suter, 2003</ce:cross-ref>). Separation and detection were performed with reversed phase chromatography coupled to tandem mass spectrometry (API 4000, Applied Biosystems, Foster City, CA, USA). Acidic and neutral pharmaceuticals (<ce:cross-ref refid="tbl1">Table 1</ce:cross-ref>) spiked to drinking water were detected according to the methods described by <ce:cross-ref refid="bib15">Löffler and Ternes (2003)</ce:cross-ref> and <ce:cross-ref refid="bib29">Ternes et al. (1998)</ce:cross-ref>.</ce:para>
                  </ce:section>
                  <ce:section view="all">
                     <ce:label>2.3</ce:label>
                     <ce:section-title>Determination of rate constants</ce:section-title>
                     <ce:para view="all">The kinetic concept, which forms the basis of the present study, has been described in detail by <ce:cross-ref refid="bib10">Hoigné and Bader (1994)</ce:cross-ref>. Because they have demonstrated that reactions of ClO<ce:inf loc="post">2</ce:inf> with inorganic and organic compounds are largely first order with respect to ClO<ce:inf loc="post">2</ce:inf> and target compound concentration, the reaction order was not investigated explicitly in the present study. To determine the rate constants for the selected pharmaceuticals, kinetic runs were performed under pseudo first-order conditions with either the target compound or ClO<ce:inf loc="post">2</ce:inf> in excess.</ce:para>
                     <ce:para view="all">Kinetic runs with excess of pharmaceuticals were conducted for the following compounds (concentrations in mM): bezafibrate (0.8), carbamazepine (0.2), diazepam (0.08), ibuprofen (0.8), iopromide (0.8), and roxithromycin (0.1). Except for roxithromycin, all solutions were buffered to pH 7 with 5<ce:hsp sp="0.16"/>mM phosphate buffer. Solutions for roxithromycin were adjusted in the pH range of 6.2 to 7.1 to investigate the pH dependency of its reactivity. The kinetic runs were started by the addition of ClO<ce:inf loc="post">2</ce:inf> doses (8–80<ce:hsp sp="0.16"/>μM) that were at least 10 times lower than the target compound concentrations. The experiments were performed in spectrophotometric cells of 35-mL volume with Suprasil quartz window and 10-cm optical path length. The cell was mounted in a temperature-stabilized metal block (20<ce:hsp sp="0.16"/>°C) inside the spectrophotometer (Kontron Instruments, Uvikon 940). ClO<ce:inf loc="post">2</ce:inf> decrease was monitored directly in the spectrophotometer. All runs were conducted in triplicate. For slow-reacting or nonreactive compounds, the decrease was monitored during 1<ce:hsp sp="0.16"/>h. For roxithromycin, half-lives of ClO<ce:inf loc="post">2</ce:inf> ranged only from 20<ce:hsp sp="0.16"/>s to 2<ce:hsp sp="0.16"/>min under the investigated conditions. Consequently, monitoring time did not exceed 4<ce:hsp sp="0.16"/>min.</ce:para>
                     <ce:para view="all">Rate constants for diclofenac, sulfamethoxazole, and EE2 were determined by monitoring their decrease in the presence of at least 10 fold excess of ClO<ce:inf loc="post">2</ce:inf>. Initial concentrations for diclofenac, sulfamethoxazole, and EE2 were 0.2, 0.15, and 0.1<ce:hsp sp="0.16"/>μM, respectively. Duplicate experiments were performed at pH 5, 6, 7, 8, 9, and 10 for diclofenac and sulfamethoxazole. Due to its increased reactivity at higher pH, the 6 experiments performed with EE2 were conducted in duplicate between pH 4 and 6. The kinetic runs were conducted in 500-mL amber glass bottles mounted with a dispenser system. They were started by the addition of the target compound. After 10<ce:hsp sp="0.16"/>s, the first sample (5<ce:hsp sp="0.16"/>mL) was withdrawn with the dispenser system. Subsequently, 5 further samples were withdrawn in suitable time intervals ranging from 10<ce:hsp sp="0.16"/>s to 2<ce:hsp sp="0.16"/>min depending on the apparent oxidation rate of the target compounds. Simultaneously, 2–5 samples were collected for ClO<ce:inf loc="post">2</ce:inf> analysis. For target compound analysis, ClO<ce:inf loc="post">2</ce:inf> residuals were immediately quenched by mixing the sample with 0.1<ce:hsp sp="0.16"/>mL sodium thiosulfate (25<ce:hsp sp="0.16"/>mM, for diclofenac and sulfamethoxazole) or ascorbic acid (25<ce:hsp sp="0.16"/>mM, for EE2). Pseudo first-order rate constants were obtained by plotting the natural logarithm of the target compound concentration versus the time. Since ClO<ce:inf loc="post">2</ce:inf> concentration typically decreased 10–20% during the course of the experiments, average concentrations were used to calculate the second-order rate constants.</ce:para>
                  </ce:section>
                  <ce:section view="all">
                     <ce:label>2.4</ce:label>
                     <ce:section-title>Oxidation in drinking water</ce:section-title>
                     <ce:para view="all">Water samples were taken at a German drinking water treatment plant (water source: bank filtrate from River Rhine) after sand filtration and immediately before the disinfectant dosing (ClO<ce:inf loc="post">2</ce:inf>, for water quality parameter see <ce:cross-ref refid="tbl2">Table 2</ce:cross-ref>
                        <ce:float-anchor refid="tbl2"/>). The samples were spiked with acidic and neutral pharmaceuticals (<ce:cross-ref refid="tbl1">Table 1</ce:cross-ref>) up to a concentration of 1<ce:hsp sp="0.16"/>μg<ce:hsp sp="0.16"/>L<ce:sup loc="post">−1</ce:sup>. The bench-scale experiments were performed at room temperature in batch reactors (500<ce:hsp sp="0.16"/>mL). The ClO<ce:inf loc="post">2</ce:inf> doses were 0.95 and 11.5<ce:hsp sp="0.16"/>mg<ce:hsp sp="0.16"/>L<ce:sup loc="post">−1</ce:sup>. After a reaction time of 30<ce:hsp sp="0.16"/>min, the oxidation reaction was stopped by adding a sodium thiosulfate solution to the reactor. The samples were then analyzed as described above.</ce:para>
                  </ce:section>
                  <ce:section view="all">
                     <ce:label>2.5</ce:label>
                     <ce:section-title>Oxidation in lake water</ce:section-title>
                     <ce:para view="all">Water from Lake Zurich, Switzerland (for water quality parameters see <ce:cross-ref refid="tbl2">Table 2</ce:cross-ref>) was buffered to pH 8 with borate buffer (10<ce:hsp sp="0.16"/>mM). To assess the competition for ClO<ce:inf loc="post">2</ce:inf> between the water matrix and pharmaceuticals, 0.3<ce:hsp sp="0.16"/>μM of iopromide, sulfamethoxazole, diclofenac, or EE2 was individually spiked in the lake water that was subsequently treated with ClO<ce:inf loc="post">2</ce:inf> doses of 0.1, 0.2, 0.5, and 1<ce:hsp sp="0.16"/>mg<ce:hsp sp="0.16"/>L<ce:sup loc="post">−1</ce:sup>. After 10<ce:hsp sp="0.16"/>min, the reaction was quenched with sodium thiosulfate (for sulfamethoxazole and diclofenac) or ascorbic acid (for iopromide and EE2). Experiments were performed in duplicate and samples were analyzed within a few hours using the HPLC methods described above.</ce:para>
                     <ce:para view="all">Experiments investigating the oxidation kinetics of sulfamethoxazole and diclofenac in lake water were conducted under the same conditions except that these experiments were only carried out for one ClO<ce:inf loc="post">2</ce:inf> dose of 0.5<ce:hsp sp="0.16"/>mg<ce:hsp sp="0.16"/>L<ce:sup loc="post">−1</ce:sup>. As a reaction vessel, 500-mL amber glass bottles with a dispenser system mounted onto the screwtop were used. Kinetic runs were started by the addition of ClO<ce:inf loc="post">2</ce:inf>. After 10, 20, 30, 50, and 70<ce:hsp sp="0.16"/>s, samples (5<ce:hsp sp="0.16"/>mL) were withdrawn with the dispenser system and immediately mixed with the sodium thiosulfate. Simultaneously, ClO<ce:inf loc="post">2</ce:inf> concentrations were measured with the LGB method.</ce:para>
                  </ce:section>
                  <ce:section view="all">
                     <ce:label>2.6</ce:label>
                     <ce:section-title>Oxidation in groundwater</ce:section-title>
                     <ce:para view="all">In the first series of experiments, groundwater from Duebendorf, Switzerland (for water quality parameters see <ce:cross-ref refid="tbl2">Table 2</ce:cross-ref>) was spiked with 1<ce:hsp sp="0.16"/>μg<ce:hsp sp="0.16"/>L<ce:sup loc="post">−1</ce:sup> of sulfapyridine, sulfathiazole, sulfamethazine, and sulfamethoxazole and 100<ce:hsp sp="0.16"/>ng<ce:hsp sp="0.16"/>L<ce:sup loc="post">−1</ce:sup> of azithromycin, clarithromycin, dehydro-erythromycin, and roxithromycin. Aliquots of 4<ce:hsp sp="0.16"/>L of the spiked water were distributed into 3 amber bottles. A ClO<ce:inf loc="post">2</ce:inf> dose of 0.1<ce:hsp sp="0.16"/>mg<ce:hsp sp="0.16"/>L<ce:sup loc="post">−1</ce:sup> was added to each bottle. From each bottle, a few samples were taken to follow the ClO<ce:inf loc="post">2</ce:inf> concentration with the ABTS method. The reaction was then stopped by the addition of sodium thiosulfate after 5<ce:hsp sp="0.16"/>min for the first bottle, after 30<ce:hsp sp="0.16"/>min for the second bottle, and after 180<ce:hsp sp="0.16"/>min for the third bottle. In the second series of experiments, the same groundwater was spiked with 1<ce:hsp sp="0.16"/>μg<ce:hsp sp="0.16"/>L<ce:sup loc="post">−1</ce:sup> of the estrogens EE2, 17<ce:italic>β</ce:italic>-estradiol, and estrone. The estrogens were treated with ClO<ce:inf loc="post">2</ce:inf> doses identical to those in the first series and the samples were obtained by a similar procedure. Analysis of the samples was performed as described above.</ce:para>
                  </ce:section>
               </ce:section>
               <ce:section view="all">
                  <ce:label>3</ce:label>
                  <ce:section-title>Results and discussion</ce:section-title>
                  <ce:para view="all">
                     <ce:cross-ref refid="tbl3">Table 3</ce:cross-ref>
                     <ce:float-anchor refid="tbl3"/> reports the second-order rate constants of selected pharmaceuticals together with theoretical half-lives at a ClO<ce:inf loc="post">2</ce:inf> concentration of 0.1<ce:hsp sp="0.16"/>mg<ce:hsp sp="0.16"/>L<ce:sup loc="post">−1</ce:sup>. Out of the 9 investigated compounds only diclofenac, 17<ce:italic>α</ce:italic>-ethinylestradiol (EE2), roxithromycin, and sulfamethoxazole showed an appreciable reactivity (see <ce:cross-ref refid="fig1">Fig. 1</ce:cross-ref>
                     <ce:float-anchor refid="fig1"/> for structures). The pH dependency of the respective rate constants is illustrated in <ce:cross-ref refid="fig2">Fig. 2</ce:cross-ref>
                     <ce:float-anchor refid="fig2"/>. EE2, roxithromycin, and sulfamethoxazole exhibit all strongly pH-dependent rate constants, which result in relative high reactivities at pH ⩾ 7. These findings can be explained by the fact that ClO<ce:inf loc="post">2</ce:inf> reacts very selectively with certain functional groups with high electron densities such as phenoxide ions and neutral tertiary amines (<ce:cross-ref refid="bib10">Hoigné and Bader, 1994</ce:cross-ref>). The reactivity of the protonated forms of these functional groups is usually many orders of magnitude lower. Therefore, the pH-dependent reactivity of EE2 and roxithromycin, which exhibit a phenolic and a tertiary amino group, respectively, can be explained by the protonation state of their reactive functional groups. The pH dependency of the reactions also implies that ClO<ce:inf loc="post">2</ce:inf> attack actually takes place at the phenolic moiety of EE2 and at the tertiary amino group of roxithromycin (<ce:cross-ref refid="fig1">Fig. 1</ce:cross-ref>). The corresponding reaction mechanisms and the expected oxidation products will be discussed later. The relatively high rate constant of the aniline derivative diclofenac indicates that the aniline group is also reactive to ClO<ce:inf loc="post">2</ce:inf>. Surprisingly, the rate constant of neutral sulfamethoxazole (<mml:math altimg="si8.gif" overflow="scroll">
                        <mml:mrow>
                           <mml:mrow>
                              <mml:mi mathvariant="normal">p</mml:mi>
                           </mml:mrow>
                           <mml:msub>
                              <mml:mrow>
                                 <mml:mi>K</mml:mi>
                              </mml:mrow>
                              <mml:mrow>
                                 <mml:mrow>
                                    <mml:mi mathvariant="normal">a</mml:mi>
                                 </mml:mrow>
                              </mml:mrow>
                           </mml:msub>
                           <mml:mo>=</mml:mo>
                           <mml:mn>5.7</mml:mn>
                        </mml:mrow>
                     </mml:math>), which also contains an aniline group, is &lt;100<ce:hsp sp="0.16"/>M<ce:sup loc="post">−1</ce:sup>
                     <ce:hsp sp="0.16"/>s<ce:sup loc="post">−1</ce:sup>. However, because the deprotonation of the acidic nitrogen of the sulfonamide moiety enhances the reactivity of sulfomethoxazole considerably, the apparent rate constant at neutral pH is similar to that of diclofenac. Fitting the measured apparent rate constants for sulfamethoxazole to a kinetic model taking into account the speciation yielded the best fit when a p<ce:italic>K</ce:italic>
                     <ce:inf loc="post">a</ce:inf> of 6.1 instead of 5.7 was used. Due to the uncertainties associated with p<ce:italic>K</ce:italic>
                     <ce:inf loc="post">a</ce:inf> determination and kinetic measurements, this deviation may not be significant and was not investigated further.</ce:para>
                  <ce:section view="all">
                     <ce:label>3.1</ce:label>
                     <ce:section-title>Oxidation in drinking water</ce:section-title>
                     <ce:para view="all">Drinking water spiked with selected pharmaceuticals (1<ce:hsp sp="0.16"/>μg<ce:hsp sp="0.16"/>L<ce:sup loc="post">−1</ce:sup>) was treated for 30<ce:hsp sp="0.16"/>min at a dose of 0.95 and 11.5<ce:hsp sp="0.16"/>mg<ce:hsp sp="0.16"/>L<ce:sup loc="post">−1</ce:sup> ClO<ce:inf loc="post">2</ce:inf>. <ce:cross-ref refid="fig3">Fig. 3</ce:cross-ref>
                        <ce:float-anchor refid="fig3"/> shows the relative residuals of pharmaceuticals for which second-order rate constants were determined in pure water (<ce:cross-ref refid="tbl3">Table 3</ce:cross-ref>). As predicted by the rate constants, bezafibrate, carbamazepine, diazepam, and ibuprofen showed no reactivity, whereas diclofenac was readily oxidized. <ce:cross-ref refid="tbl4">Table 4</ce:cross-ref>
                        <ce:float-anchor refid="tbl4"/> reports the residual concentrations of further pharmaceuticals investigated in the same experiments. Based on this data, the second-order rate constants given in the last column of <ce:cross-ref refid="tbl4">Table 4</ce:cross-ref> were estimated. Among these pharmaceuticals, only phenazone derivatives and naproxen exhibited an appreciable reactivity. Due to the relatively high reactivity of phenazone derivatives, only a lower limit of the rate constants could be estimated for these compounds.</ce:para>
                  </ce:section>
                  <ce:section view="all">
                     <ce:label>3.2</ce:label>
                     <ce:section-title>Oxidation in lake water</ce:section-title>
                     <ce:para view="all">In water treatment, ClO<ce:inf loc="post">2</ce:inf> is also applied for preoxidation of surface water. To find out whether the rate constants determined in pure water can be applied to predict the oxidation kinetics of pharmaceuticals in natural surface waters, water from Lake Zurich was spiked with selected pharmaceuticals and treated with ClO<ce:inf loc="post">2</ce:inf>. To predict the extent of parent compound oxidation of a pharmaceutical compound (P), the following equation can be used:<ce:display>
                           <ce:formula id="eq1">
                              <ce:label>(1)</ce:label>
                              <mml:math altimg="si1.gif" overflow="scroll">
                                 <mml:mrow>
                                    <mml:mfrac>
                                       <mml:mrow>
                                          <mml:mo stretchy="false">[</mml:mo>
                                          <mml:mi>P</mml:mi>
                                          <mml:msub>
                                             <mml:mrow>
                                                <mml:mo stretchy="false">]</mml:mo>
                                             </mml:mrow>
                                             <mml:mrow>
                                                <mml:mi>τ</mml:mi>
                                             </mml:mrow>
                                          </mml:msub>
                                       </mml:mrow>
                                       <mml:mrow>
                                          <mml:mo stretchy="false">[</mml:mo>
                                          <mml:mi>P</mml:mi>
                                          <mml:msub>
                                             <mml:mrow>
                                                <mml:mo stretchy="false">]</mml:mo>
                                             </mml:mrow>
                                             <mml:mrow>
                                                <mml:mn>0</mml:mn>
                                             </mml:mrow>
                                          </mml:msub>
                                       </mml:mrow>
                                    </mml:mfrac>
                                    <mml:mo>=</mml:mo>
                                    <mml:msup>
                                       <mml:mrow>
                                          <mml:mrow>
                                             <mml:mi mathvariant="normal">e</mml:mi>
                                          </mml:mrow>
                                       </mml:mrow>
                                       <mml:mrow>
                                          <mml:mrow>
                                             <mml:mo>-</mml:mo>
                                             <mml:msub>
                                                <mml:mrow>
                                                   <mml:mi>k</mml:mi>
                                                </mml:mrow>
                                                <mml:mrow>
                                                   <mml:mrow>
                                                      <mml:msub>
                                                         <mml:mrow>
                                                            <mml:mrow>
                                                               <mml:mi mathvariant="normal">ClO</mml:mi>
                                                            </mml:mrow>
                                                         </mml:mrow>
                                                         <mml:mrow>
                                                            <mml:mrow>
                                                               <mml:mn>2</mml:mn>
                                                            </mml:mrow>
                                                         </mml:mrow>
                                                      </mml:msub>
                                                   </mml:mrow>
                                                </mml:mrow>
                                             </mml:msub>
                                             <mml:msubsup>
                                                <mml:mo mathvariant="italic">∫</mml:mo>
                                                <mml:mrow>
                                                   <mml:mn>0</mml:mn>
                                                </mml:mrow>
                                                <mml:mrow>
                                                   <mml:mi>τ</mml:mi>
                                                </mml:mrow>
                                             </mml:msubsup>
                                             <mml:mrow>
                                                <mml:mo stretchy="false">[</mml:mo>
                                                <mml:msub>
                                                   <mml:mrow>
                                                      <mml:mrow>
                                                         <mml:mi mathvariant="normal">ClO</mml:mi>
                                                      </mml:mrow>
                                                   </mml:mrow>
                                                   <mml:mrow>
                                                      <mml:mn>2</mml:mn>
                                                   </mml:mrow>
                                                </mml:msub>
                                                <mml:mo stretchy="false">]</mml:mo>
                                                <mml:mspace width=".16em"/>
                                                <mml:mrow>
                                                   <mml:mi mathvariant="normal">d</mml:mi>
                                                </mml:mrow>
                                                <mml:mi>t</mml:mi>
                                             </mml:mrow>
                                          </mml:mrow>
                                       </mml:mrow>
                                    </mml:msup>
                                    <mml:mtext>,</mml:mtext>
                                 </mml:mrow>
                              </mml:math>
                           </ce:formula>
                        </ce:display>where <mml:math altimg="si2.gif" overflow="scroll">
                           <mml:mrow>
                              <mml:msub>
                                 <mml:mrow>
                                    <mml:mi>k</mml:mi>
                                 </mml:mrow>
                                 <mml:mrow>
                                    <mml:mrow>
                                       <mml:msub>
                                          <mml:mrow>
                                             <mml:mrow>
                                                <mml:mi mathvariant="normal">ClO</mml:mi>
                                             </mml:mrow>
                                          </mml:mrow>
                                          <mml:mrow>
                                             <mml:mn>2</mml:mn>
                                          </mml:mrow>
                                       </mml:msub>
                                    </mml:mrow>
                                 </mml:mrow>
                              </mml:msub>
                           </mml:mrow>
                        </mml:math> is the second-order rate constant for the reaction with ClO<ce:inf loc="post">2</ce:inf> and <mml:math altimg="si3.gif" overflow="scroll">
                           <mml:mrow>
                              <mml:msubsup>
                                 <mml:mo mathvariant="italic">∫</mml:mo>
                                 <mml:mrow>
                                    <mml:mn>0</mml:mn>
                                 </mml:mrow>
                                 <mml:mrow>
                                    <mml:mi>τ</mml:mi>
                                 </mml:mrow>
                              </mml:msubsup>
                              <mml:mrow>
                                 <mml:mo stretchy="false">[</mml:mo>
                                 <mml:msub>
                                    <mml:mrow>
                                       <mml:mrow>
                                          <mml:mi mathvariant="normal">ClO</mml:mi>
                                       </mml:mrow>
                                    </mml:mrow>
                                    <mml:mrow>
                                       <mml:mn>2</mml:mn>
                                    </mml:mrow>
                                 </mml:msub>
                                 <mml:mo stretchy="false">]</mml:mo>
                                 <mml:mspace width=".16em"/>
                                 <mml:mrow>
                                    <mml:mi mathvariant="normal">d</mml:mi>
                                 </mml:mrow>
                                 <mml:mi>t</mml:mi>
                              </mml:mrow>
                           </mml:mrow>
                        </mml:math> the chlorine dioxide exposure (ClO<ce:inf loc="post">2</ce:inf> concentration integrated over time) from <mml:math altimg="si9.gif" overflow="scroll">
                           <mml:mrow>
                              <mml:mi>t</mml:mi>
                              <mml:mo>=</mml:mo>
                              <mml:mn>0</mml:mn>
                           </mml:mrow>
                        </mml:math> to τ. Consequently, predictions according to Eq. <ce:cross-ref refid="eq1">(1)</ce:cross-ref> can be made, if <mml:math altimg="si4.gif" overflow="scroll">
                           <mml:mrow>
                              <mml:msub>
                                 <mml:mrow>
                                    <mml:mi>k</mml:mi>
                                 </mml:mrow>
                                 <mml:mrow>
                                    <mml:mrow>
                                       <mml:msub>
                                          <mml:mrow>
                                             <mml:mrow>
                                                <mml:mi mathvariant="normal">ClO</mml:mi>
                                             </mml:mrow>
                                          </mml:mrow>
                                          <mml:mrow>
                                             <mml:mn>2</mml:mn>
                                          </mml:mrow>
                                       </mml:msub>
                                    </mml:mrow>
                                 </mml:mrow>
                              </mml:msub>
                           </mml:mrow>
                        </mml:math> and the respective chlorine dioxide exposure are known. <ce:cross-ref refid="fig4">Fig. 4</ce:cross-ref>
                        <ce:float-anchor refid="fig4"/> depicts the oxidation of sulfamethoxazole and diclofenac for a ClO<ce:inf loc="post">2</ce:inf> dose of 0.5<ce:hsp sp="0.16"/>mg<ce:hsp sp="0.16"/>L<ce:sup loc="post">−1</ce:sup> (symbols represent experimental data; lines represent predictions). As predicted, both compounds were oxidized by more than 90% within 60<ce:hsp sp="0.16"/>s. This demonstrates clearly that the determined rate constants can be applied for the description of ClO<ce:inf loc="post">2</ce:inf> oxidation processes in natural waters.</ce:para>
                     <ce:para view="all">When ClO<ce:inf loc="post">2</ce:inf> is applied to a surface water that has a substantial ClO<ce:inf loc="post">2</ce:inf> demand, pharmaceuticals and the water matrix will compete for ClO<ce:inf loc="post">2</ce:inf> and even highly reactive pharmaceuticals may not be completely transformed below a certain ClO<ce:inf loc="post">2</ce:inf> dose. <ce:cross-ref refid="fig5">Fig. 5</ce:cross-ref>
                        <ce:float-anchor refid="fig5"/> illustrates this competition for Lake Zurich water for various ClO<ce:inf loc="post">2</ce:inf> doses between 0.1 and 1<ce:hsp sp="0.16"/>mg<ce:hsp sp="0.16"/>L<ce:sup loc="post">−1</ce:sup>. As expected, the ClO<ce:inf loc="post">2</ce:inf> dose required to oxidize a pharmaceutical compound to more than 95% decreased with increasing rate constants. For sulfamethoxazole, a residual could still be detected after treatment with 0.2<ce:hsp sp="0.16"/>mg<ce:hsp sp="0.16"/>L<ce:sup loc="post">−1</ce:sup> ClO<ce:inf loc="post">2</ce:inf>, whereas for EE2, which has the highest rate constant, a dose of 0.1<ce:hsp sp="0.16"/>mg<ce:hsp sp="0.16"/>L<ce:sup loc="post">−1</ce:sup> was sufficient to oxidize it to a residual accounting for 3% of its initial concentration.</ce:para>
                  </ce:section>
                  <ce:section view="all">
                     <ce:label>3.3</ce:label>
                     <ce:section-title>Oxidation in groundwater</ce:section-title>
                     <ce:para view="all">ClO<ce:inf loc="post">2</ce:inf> is often dosed to finished drinking water as a final disinfectant. In this case, very low ClO<ce:inf loc="post">2</ce:inf> doses can be applied because this water does not usually exhibit a high ClO<ce:inf loc="post">2</ce:inf> demand (good quality groundwater or treated surface water). To simulate such conditions, groundwater was spiked with 4 sulfonamide (1<ce:hsp sp="0.16"/>μg<ce:hsp sp="0.16"/>L<ce:sup loc="post">−1</ce:sup> each) and 4 macrolide antibiotics (100<ce:hsp sp="0.16"/>ng<ce:hsp sp="0.16"/>L<ce:sup loc="post">−1</ce:sup> each) as well as 3 estrogens (1<ce:hsp sp="0.16"/>μg<ce:hsp sp="0.16"/>L<ce:sup loc="post">−1</ce:sup> each) and subsequently treated with 0.1<ce:hsp sp="0.16"/>mg<ce:hsp sp="0.16"/>L<ce:sup loc="post">−1</ce:sup> ClO<ce:inf loc="post">2</ce:inf>. The half-life of ClO<ce:inf loc="post">2</ce:inf> was approximately 15<ce:hsp sp="0.16"/>min under these conditions. <ce:cross-ref refid="fig6">Fig. 6</ce:cross-ref>
                        <ce:float-anchor refid="fig6"/> shows the relative residual concentrations of the investigated compounds measured after 5, 30, and 180<ce:hsp sp="0.16"/>min.</ce:para>
                     <ce:para view="all">The investigated sulfonamides sulfamethoxazole, sulfamethazine, sulfapyridine, and sulfathiazole were oxidized to more than 95% after 30<ce:hsp sp="0.16"/>min of contact time. Despite structural similarities, in particular the common aniline group that is expected to be reactive toward ClO<ce:inf loc="post">2</ce:inf>, the reactivity of the different sulfonamides varied somewhat more than expected. These variations can be explained to some extent by the differences in speciation. Based on the results for sulfamethoxazole, the reactivity of the sulfonamides seems strongly influenced by the protonation state of the acidic nitrogen of the sulfonamide group. The p<ce:italic>K</ce:italic>
                        <ce:inf loc="post">a</ce:inf> value of this nitrogen ranges from 5.7 for sulfamethoxazole to 8.4 for sulfapyridine. Accordingly, sulfapyridine was predominantly present in its neutral form in the groundwater and therefore less reactive. However, it cannot be excluded that some of the differences are also caused by the fact that ClO<ce:inf loc="post">2</ce:inf> attack does not occur primarily on the aniline moiety but rather on the sulfur bearing thiazole group of sulfathiazole or on the isoxazole moiety of sulfamethoxazole.</ce:para>
                     <ce:para view="all">The investigated macrolides azithromycin, clarithromycin, dehydro-erythromycin, and roxithromycin were oxidized more slowly than the sulfonamides and the extent of parent compound oxidation reached &gt;80% only after 180<ce:hsp sp="0.16"/>min. This can be expected from their lower apparent rate constants for the reaction with ClO<ce:inf loc="post">2</ce:inf>. According to their common reactive moiety (tertiary amino group), the oxidation pattern for all compounds is very similar. However, it has to be taken into account that standard deviations for some of the macrolides were unusually large. The large errors could be the result of problems with the solid phase extraction. The precision of sulfonamide measurements was much better due to the use of better surrogate standards (structurally identical isotope-labeled compounds instead of structurally similar compounds).</ce:para>
                     <ce:para view="all">The estrogens EE2, 17<ce:italic>β</ce:italic>-estradiol, and estrone reacted too fast to be detected after 5<ce:hsp sp="0.16"/>min contact time. As expected on the basis of their similar structures, 17<ce:italic>β</ce:italic>-estradiol, and estrone must exhibit a similar rate constant as EE2. Overall, the results for the groundwater experiments show that the rate constants for sulfamethoxazole, roxithromycin, and EE2 can be taken as rough estimates for the rate constants of other pharmaceuticals (hormones) belonging to the same chemical class.</ce:para>
                     <ce:para view="all">In <ce:cross-ref refid="fig7">Fig. 7</ce:cross-ref>
                        <ce:float-anchor refid="fig7"/>, the relative residuals predicted on the basis of the ClO<ce:inf loc="post">2</ce:inf> exposure (Eq. <ce:cross-ref refid="eq1">(1)</ce:cross-ref>) and the measured residuals of roxithromycin and sulfamethoxazole are plotted as a function of time. To give an estimate for the uncertainty associated with the used model, the minimal and maximal residuals are also indicated (dashed lines), predicted on the basis of minimal and maximal values for the rate constant of roxithromycin and the chlorine dioxide concentrations. Unfortunately, the measurements for roxithromycin were not very precise. Nevertheless, it can be concluded that predictions and measured data agreed reasonably well for both compounds. This demonstrated that the rate constants determined in pure water at high concentrations of target compounds can be applied to natural waters containing realistic concentrations of pharmaceuticals.</ce:para>
                  </ce:section>
                  <ce:section view="all">
                     <ce:label>3.4</ce:label>
                     <ce:section-title>Oxidation products</ce:section-title>
                     <ce:para view="all">Oxidative treatment should not only lead to the disappearance of parent compounds, but also destroy biological effects of pharmaceuticals. Because full mineralization is generally not achievable with oxidant doses commonly used in water treatment, oxidative treatment can only deactivate pharmaceuticals by selectively oxidizing functional groups that are crucial for their effects. To date, little is known about the oxidation products resulting from the reaction of ClO<ce:inf loc="post">2</ce:inf> with pharmaceuticals. However, the work of <ce:cross-ref refid="bib22">Rosenblatt et al. (1967)</ce:cross-ref> provides strong evidence that ClO<ce:inf loc="post">2</ce:inf> attack of tertiary amines leads to the cleavage of one of the N–C bonds. In the case of the macrolide antibiotics, this reaction will result in the loss of a methyl group or the loss of the whole amino group. <ce:cross-ref refid="bib14">Li et al. (2001)</ce:cross-ref> have shown that the antibiotic activity of demethylated roxithromycin is much lower than that of the parent compound.</ce:para>
                     <ce:para view="all">For ozone, it could be shown that most probably small modifications of the phenolic moiety of EE2 (caused by substoichiometric ozone doses) were sufficient to reduce its estrogenicity significantly (<ce:cross-ref refid="bib12">Huber et al., 2004</ce:cross-ref>). It is expected that the oxidation of EE2 by ClO<ce:inf loc="post">2</ce:inf> yields quinone type products similar to those from the initial oxidation by ozone (<ce:cross-ref refid="bib20">Rav-Acha, 1984</ce:cross-ref>). Therefore, treatment with ClO<ce:inf loc="post">2</ce:inf> could decrease the estrogenic activity of EE2, even though the phenolic moiety will probably not be cleaved to the same extent as under typical treatment conditions for ozonation. On the basis of these considerations, it can be assumed that treatment with ClO<ce:inf loc="post">2</ce:inf> does not only result in the disappearance of macrolides and estrogens, but also potentially reduces their pharmacological effects.</ce:para>
                  </ce:section>
                  <ce:section view="all">
                     <ce:label>3.5</ce:label>
                     <ce:section-title>Comparison of chlorine dioxide with ozone and chlorine</ce:section-title>
                     <ce:para view="all">It is of great interest to compare the rate constants determined for ClO<ce:inf loc="post">2</ce:inf> with rate constants for other oxidants used in water treatment such as chlorine and ozone. Recent publications on ozonation (<ce:cross-ref refid="bib11">Huber et al., 2003</ce:cross-ref>) and chlorination (<ce:cross-ref refid="bib18">Pinkston and Sedlak, 2004</ce:cross-ref>; <ce:cross-ref refid="bib6">Dodd and Huang, 2004</ce:cross-ref>) of pharmaceuticals, as well as some chlorination experiments performed within the framework of this study, provided a set of rate constants that can be compared to those of chlorine dioxide. In <ce:cross-ref refid="fig8">Fig. 8</ce:cross-ref>
                        <ce:float-anchor refid="fig8"/>, the rate constants of these compounds are presented as apparent rate constant at pH 7. Furthermore, theoretical half-lives are given for an oxidant concentration of 1<ce:hsp sp="0.16"/>mg<ce:hsp sp="0.16"/>L<ce:sup loc="post">−1</ce:sup>. Reactions with ozone are clearly the fastest and result in the shortest half-lives. Additionally, ozone reacts with the largest number of compounds. The apparent rate constants for the reaction with ClO<ce:inf loc="post">2</ce:inf> are roughly 2 orders of magnitude lower than ozone rate constants, but higher (to varying extents) than chlorine rate constants. However, the latter observation cannot be generalized, because functional groups like aliphatic primary and secondary amines are known to react significantly faster with chlorine than chlorine dioxide (<ce:cross-ref refid="bib16">Pattison and Davis, 2001</ce:cross-ref>; <ce:cross-ref refid="bib1">Abia et al., 1998</ce:cross-ref>; <ce:cross-ref refid="bib10">Hoigné and Bader, 1994</ce:cross-ref>). For the limited number of pharmaceuticals presented here, it was shown that ClO<ce:inf loc="post">2</ce:inf> and chlorine react with the same compounds. Both oxidants react primarily with electron rich functional groups like amines and phenols. Ozone reacts with the same functional groups, however, additionally with <mml:math altimg="si5.gif" overflow="scroll">
                           <mml:mrow>
                              <mml:mrow>
                                 <mml:mi mathvariant="normal">C</mml:mi>
                              </mml:mrow>
                           </mml:mrow>
                           <mml:mtext>
                              <ce:glyph name="dbnd"/>
                           </mml:mtext>
                           <mml:mrow>
                              <mml:mi mathvariant="normal">C</mml:mi>
                           </mml:mrow>
                        </mml:math> double bonds and activated benzene rings. With respect to ozone, it has also to be taken into account that hydroxyl radicals, formed due to ozone decay, can oxidize ozone refractive pharmaceuticals to a substantial extent (<ce:cross-ref refid="bib11">Huber et al., 2003</ce:cross-ref>).</ce:para>
                  </ce:section>
               </ce:section>
               <ce:section view="all">
                  <ce:label>4</ce:label>
                  <ce:section-title>Conclusions</ce:section-title>
                  <ce:para view="all">Macrolide and sulfonamide antibiotics as well as estrogens and phenazones are readily oxidized by ClO<ce:inf loc="post">2</ce:inf>. However, many of the investigated compounds did not react at an appreciable rate with ClO<ce:inf loc="post">2</ce:inf>. Therefore, it can be concluded that ClO<ce:inf loc="post">2</ce:inf> applied in water treatment only acts as a partial barrier for pharmaceuticals, even though it is relatively effective in oxidizing antibiotics and estrogens, two compound classes that merit special concern due to their high biological activity. Ozone seems to be considerably more efficient for pharmaceutical control than ClO<ce:inf loc="post">2</ce:inf> because it exhibits higher rate constants and reacts with a larger number of pharmaceuticals. However, ClO<ce:inf loc="post">2</ce:inf> appears slightly more powerful than chlorine for the oxidation of pharmaceuticals. For a more comprehensive comparison of these oxidants, additional knowledge about the formation of oxidation products and their pharmacological or biological effects would be necessary.</ce:para>
               </ce:section>
            </ce:sections>
            <ce:acknowledgment>
               <ce:section-title>Acknowledgments</ce:section-title>
               <ce:para view="all">We thank Anke Göbel, Nadine Herrmann and Matthias Bonerz for their assistance with respect to sample analysis. We also thank Gretchen Onstad for reviewing the manuscript. This study was performed within the framework of POSEIDON, European Union project EVK1-CT-2000-00047. Financial support by BBW (Bundesamt für Bildung und Wissenschaft) is gratefully acknowledged.</ce:para>
            </ce:acknowledgment>
         </body>
         <tail view="all">
            <ce:bibliography view="all">
               <ce:section-title>References</ce:section-title>
               <ce:bibliography-sec>
                  <ce:bib-reference id="bib1">
                     <ce:label>Abia et al., 1998</ce:label>
                     <sb:reference>
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Abia</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>X.L.</ce:given-name>
                                 <ce:surname>Armesto</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.M.</ce:given-name>
                                 <ce:surname>Canle</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.V.</ce:given-name>
                                 <ce:surname>Garcia</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.A.</ce:given-name>
                                 <ce:surname>Santaballa</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Oxidation of aliphatic amines by aqueous chlorine</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Tetrahedron</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>54</sb:volume-nr>
                              </sb:series>
                              <sb:date>1998</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>521</sb:first-page>
                              <sb:last-page>530</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib2">
                     <ce:label>Chen and Regli, 2002</ce:label>
                     <sb:reference>
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Chen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Regli</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Disinfection practices and pathogen inactivation in ICR surface water plants</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:edited-book>
                              <sb:editors>
                                 <sb:editor>
                                    <ce:given-name>M.J.</ce:given-name>
                                    <ce:surname>McGuire</ce:surname>
                                 </sb:editor>
                                 <sb:editor>
                                    <ce:given-name>J.L.</ce:given-name>
                                    <ce:surname>McLain</ce:surname>
                                 </sb:editor>
                                 <sb:editor>
                                    <ce:given-name>A.</ce:given-name>
                                    <ce:surname>Obolensky</ce:surname>
                                 </sb:editor>
                              </sb:editors>
                              <sb:title>
                                 <sb:maintitle>Information Collection Rule Analysis Data</sb:maintitle>
                              </sb:title>
                              <sb:date>2002</sb:date>
                              <sb:publisher>
                                 <sb:name>Awwa Research Foundation and American Water Works Association</sb:name>
                              </sb:publisher>
                           </sb:edited-book>
                           <sb:pages>
                              <sb:first-page>371</sb:first-page>
                              <sb:last-page>394</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib3">
                     <ce:label>Chiswell and O’Halloran, 1991</ce:label>
                     <sb:reference>
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Chiswell</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.R.</ce:given-name>
                                 <ce:surname>O’Halloran</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Use of lissamine green B as a spectrophotometric reagent for the determination of low residuals of chlorine dioxide</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Analyst</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>116</sb:volume-nr>
                              </sb:series>
                              <sb:date>1991</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>657</sb:first-page>
                              <sb:last-page>661</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib4">
                     <ce:label>Condie, 1986</ce:label>
                     <ce:other-ref>
                        <ce:textref>Condie, L.W., 1986. Toxicological problems associated with chlorine dioxide. J. Am. Water Works Assoc. June, 73–78.</ce:textref>
                     </ce:other-ref>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib5">
                     <ce:label>Deborde et al., 2004</ce:label>
                     <ce:other-ref>
                        <ce:textref>Deborde, M., Rabouan, S., Gallard, H., Legube, B., 2004. Aqueous chlorination kinetics of some endocrine disruptors. Environ. Sci. Technol., web release date: September 22.</ce:textref>
                     </ce:other-ref>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib6">
                     <ce:label>Dodd et al., 2004</ce:label>
                     <ce:other-ref>
                        <ce:textref>Dodd, M.C., Huang, C.-H., 2004. Transformation of the antibacterial agent sulfamethoxazole in reactions with chlorine: kinetics, mechanisms, and pathways. Environ. Sci. Technol., in press.</ce:textref>
                     </ce:other-ref>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib7">
                     <ce:label>Gates, 1998</ce:label>
                     <sb:reference>
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Gates</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>The Chlorine Dioxide Handbook</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:book>
                              <sb:date>1998</sb:date>
                              <sb:publisher>
                                 <sb:name>American Water Works Association</sb:name>
                                 <sb:location>Denver</sb:location>
                              </sb:publisher>
                           </sb:book>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib8">
                     <ce:label>Göbel et al., 2004</ce:label>
                     <sb:reference>
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Göbel</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.S.</ce:given-name>
                                 <ce:surname>McArdell</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.J.-F.</ce:given-name>
                                 <ce:surname>Suter</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Giger</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Trace determination of macrolide and sulfonamide antimicrobials, a human sulfonamide metabolite, and trimethoprim in wastewater using liquid chromatography coupled to electrospray tandem mass spectrometry</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Anal. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>76</sb:volume-nr>
                              </sb:series>
                              <sb:date>2004</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>4756</sb:first-page>
                              <sb:last-page>4764</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib9">
                     <ce:label>Hirsch et al., 1999</ce:label>
                     <sb:reference>
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Hirsch</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.A.</ce:given-name>
                                 <ce:surname>Ternes</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Haberer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.-L.</ce:given-name>
                                 <ce:surname>Kratz</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Occurrence of antibiotics in the aquatic environment</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Sci. Total Environ.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>225</sb:volume-nr>
                              </sb:series>
                              <sb:date>1999</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>109</sb:first-page>
                              <sb:last-page>118</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib10">
                     <ce:label>Hoigné and Bader, 1994</ce:label>
                     <sb:reference>
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Hoigné</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Bader</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Kinetics of reactions of chlorine dioxide (OClO) in water—I Rate constants for inorganic and organic compounds</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Water Res.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>28</sb:volume-nr>
                              </sb:series>
                              <sb:date>1994</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>45</sb:first-page>
                              <sb:last-page>55</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib11">
                     <ce:label>Huber et al., 2003</ce:label>
                     <sb:reference>
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>M.M.</ce:given-name>
                                 <ce:surname>Huber</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Canonica</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.-Y.</ce:given-name>
                                 <ce:surname>Park</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>U.</ce:given-name>
                                 <ce:surname>von Gunten</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Oxidation of pharmaceuticals during ozonation and advanced oxidation processes</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Environ. Sci. Technol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>37</sb:volume-nr>
                              </sb:series>
                              <sb:date>2003</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1016</sb:first-page>
                              <sb:last-page>1024</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib12">
                     <ce:label>Huber et al., 2004</ce:label>
                     <sb:reference>
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>M.M.</ce:given-name>
                                 <ce:surname>Huber</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.A.</ce:given-name>
                                 <ce:surname>Ternes</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>U.</ce:given-name>
                                 <ce:surname>von Gunten</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Removal of estrogenic activity and formation of oxidation products during ozonation of 17<ce:italic>α</ce:italic>-ethinylestradiol</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Environ. Sci. Technol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>38</sb:volume-nr>
                              </sb:series>
                              <sb:date>2004</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>5177</sb:first-page>
                              <sb:last-page>5186</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib13">
                     <ce:label>Kolpin et al., 2002</ce:label>
                     <sb:reference>
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>D.W.</ce:given-name>
                                 <ce:surname>Kolpin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.T.</ce:given-name>
                                 <ce:surname>Furlong</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.T.</ce:given-name>
                                 <ce:surname>Meyer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.M.</ce:given-name>
                                 <ce:surname>Thurman</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.D.</ce:given-name>
                                 <ce:surname>Zaugg</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.B.</ce:given-name>
                                 <ce:surname>Barber</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.T.</ce:given-name>
                                 <ce:surname>Buxton</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999–2000: a national reconnaissance</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Environ. Sci. Technol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>36</sb:volume-nr>
                              </sb:series>
                              <sb:date>2002</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1202</sb:first-page>
                              <sb:last-page>1211</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib14">
                     <ce:label>Li et al., 2001</ce:label>
                     <sb:reference>
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>X.-Q.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.-F.</ce:given-name>
                                 <ce:surname>Zhong</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.-H.</ce:given-name>
                                 <ce:surname>Huang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.-D.</ce:given-name>
                                 <ce:surname>Wu</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Demethylation metabolism of roxithromycin in humans and rats</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Acta Pharmacol. Sin.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>22</sb:volume-nr>
                              </sb:series>
                              <sb:date>2001</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>469</sb:first-page>
                              <sb:last-page>474</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib15">
                     <ce:label>Löffler and Ternes, 2003</ce:label>
                     <sb:reference>
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Löffler</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.A.</ce:given-name>
                                 <ce:surname>Ternes</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Analysis of acidic pharmaceuticals, antibiotics and ivermectin in river sediments using LC-tandem MS</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Chromatogr. A</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>1021</sb:volume-nr>
                              </sb:series>
                              <sb:date>2003</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>133</sb:first-page>
                              <sb:last-page>144</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib16">
                     <ce:label>Pattison and Davis, 2001</ce:label>
                     <sb:reference>
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>D.I.</ce:given-name>
                                 <ce:surname>Pattison</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.J.</ce:given-name>
                                 <ce:surname>Davis</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Absolute rate constants for the reaction of hypochlorous acid with protein side chains and peptide bonds</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Chem. Res. Toxicol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>14</sb:volume-nr>
                              </sb:series>
                              <sb:date>2001</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1453</sb:first-page>
                              <sb:last-page>1464</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib17">
                     <ce:label>Pinkernell et al., 2000</ce:label>
                     <sb:reference>
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>U.</ce:given-name>
                                 <ce:surname>Pinkernell</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Nowack</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Gallard</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>U.</ce:given-name>
                                 <ce:surname>von Gunten</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Methods for the photometric determination of reactive bromine and chlorine species with ABTS</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Water Res.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>34</sb:volume-nr>
                              </sb:series>
                              <sb:date>2000</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>4343</sb:first-page>
                              <sb:last-page>4350</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib18">
                     <ce:label>Pinkston and Sedlak, 2004</ce:label>
                     <sb:reference>
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>K.E.</ce:given-name>
                                 <ce:surname>Pinkston</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.L.</ce:given-name>
                                 <ce:surname>Sedlak</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Transformation of aromatic ether- and amine-containing pharmaceuticals during chlorine disinfection</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Environ. Sci. Technol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>38</sb:volume-nr>
                              </sb:series>
                              <sb:date>2004</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>4019</sb:first-page>
                              <sb:last-page>4025</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib19">
                     <ce:label>Poseidon Report, 2004</ce:label>
                     <ce:other-ref>
                        <ce:textref>Poseidon Final Report, 2004. Detailed report of the EU-project Poseidon (EVK1-CT-2000-000479), <ce:inter-ref xlink:href="http://www.eu-poseidon" xlink:type="simple">www.eu-poseidon</ce:inter-ref>.com.</ce:textref>
                     </ce:other-ref>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib20">
                     <ce:label>Rav-Acha, 1984</ce:label>
                     <sb:reference>
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Rav-Acha</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>The reaction of chlorine dioxide with aquatic organic materials and their health effects</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Water Res.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>18</sb:volume-nr>
                              </sb:series>
                              <sb:date>1984</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1329</sb:first-page>
                              <sb:last-page>1341</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib21">
                     <ce:label>Reddersen et al., 2002</ce:label>
                     <sb:reference>
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Reddersen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Heberer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>U.</ce:given-name>
                                 <ce:surname>Dünnbier</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Identification and significance of phenazone drugs and their metabolites in ground- and drinking water</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Chemosphere</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>49</sb:volume-nr>
                              </sb:series>
                              <sb:date>2002</sb:date>
                           </sb:issue>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib22">
                     <ce:label>Rosenblatt et al., 1967</ce:label>
                     <sb:reference>
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>D.H.</ce:given-name>
                                 <ce:surname>Rosenblatt</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.A.</ce:given-name>
                                 <ce:surname>Hull</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.C.</ce:given-name>
                                 <ce:surname>De Luca</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.T.</ce:given-name>
                                 <ce:surname>Davis</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.C.</ce:given-name>
                                 <ce:surname>Weglein</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.K.R.</ce:given-name>
                                 <ce:surname>Williams</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Oxidations of amines. II. Substituent effects in chlorine dioxide oxidations</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Am. Chem. Soc.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>98</sb:volume-nr>
                              </sb:series>
                              <sb:date>1967</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1158</sb:first-page>
                              <sb:last-page>1163</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib23">
                     <ce:label>Sacher et al., 2001</ce:label>
                     <sb:reference>
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Sacher</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.F.</ce:given-name>
                                 <ce:surname>Lange</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.-J.</ce:given-name>
                                 <ce:surname>Brauch</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>I.</ce:given-name>
                                 <ce:surname>Blankenhorn</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Pharmaceuticals in groundwaters: analytical methods and results of monitoring program in Baden-Württemberg, Germany</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Chromatogr. A</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>938</sb:volume-nr>
                              </sb:series>
                              <sb:date>2001</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>199</sb:first-page>
                              <sb:last-page>210</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib24">
                     <ce:label>Schönenberger and Suter, 2003</ce:label>
                     <sb:reference>
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Schönenberger</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.J.-F.</ce:given-name>
                                 <ce:surname>Suter</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Standard operating procedure for the determination of steroid hormones using LC-MS/MS</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:book>
                              <sb:date>2003</sb:date>
                              <sb:publisher>
                                 <sb:name>EAWAG, Dübendorf</sb:name>
                                 <sb:location>Switzerland</sb:location>
                              </sb:publisher>
                           </sb:book>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib25">
                     <ce:label>Stackelberg et al., 2004</ce:label>
                     <sb:reference>
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>P.E.</ce:given-name>
                                 <ce:surname>Stackelberg</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.T.</ce:given-name>
                                 <ce:surname>Furlong</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.T.</ce:given-name>
                                 <ce:surname>Meyer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.D.</ce:given-name>
                                 <ce:surname>Zaugg</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.K.</ce:given-name>
                                 <ce:surname>Henderson</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.B.</ce:given-name>
                                 <ce:surname>Reissman</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking-water-treatment plant</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Sci. Total Environ.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>329</sb:volume-nr>
                              </sb:series>
                              <sb:date>2004</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>99</sb:first-page>
                              <sb:last-page>113</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib26">
                     <ce:label>Ternes, 1998</ce:label>
                     <sb:reference>
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>T.A.</ce:given-name>
                                 <ce:surname>Ternes</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Occurrence of drugs in German sewage treatment plants and rivers</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Water Res.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>32</sb:volume-nr>
                              </sb:series>
                              <sb:date>1998</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>3245</sb:first-page>
                              <sb:last-page>3260</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib27">
                     <ce:label>Ternes, 2001</ce:label>
                     <ce:other-ref>
                        <ce:textref>Ternes, T.A., 2001. Pharmaceuticals and metabolites as contaminants of the aquatic environment. In: Daughton, C.G., Jones-Lepp, T.L. (Eds.), Pharmaceuticals and Personal Care Products in the Environment: Scientific Regulatory Issue, ACS-Symposium Series, pp. 39–54.</ce:textref>
                     </ce:other-ref>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib28">
                     <ce:label>Ternes and Hirsch, 2000</ce:label>
                     <sb:reference>
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>T.A.</ce:given-name>
                                 <ce:surname>Ternes</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Hirsch</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Occurrence and behaviour of X-ray contrast media in sewage facilities and the aquatic environment</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Environ. Sci. Technol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>34</sb:volume-nr>
                              </sb:series>
                              <sb:date>2000</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>2741</sb:first-page>
                              <sb:last-page>2748</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib29">
                     <ce:label>Ternes et al., 1998</ce:label>
                     <sb:reference>
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>T.A.</ce:given-name>
                                 <ce:surname>Ternes</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Hirsch</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Müller</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Haberer</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Method for the determination of neutral drugs as well as betablockers and sympathomimetics in aqueous matrices using GC/MS and LC/MS/MS</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Fresenius J. Anal. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>362</sb:volume-nr>
                              </sb:series>
                              <sb:date>1998</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>329</sb:first-page>
                              <sb:last-page>340</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib30">
                     <ce:label>Ternes et al., 2002</ce:label>
                     <sb:reference>
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>T.A.</ce:given-name>
                                 <ce:surname>Ternes</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Meisenheimer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>McDowell</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Sacher</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.-J.</ce:given-name>
                                 <ce:surname>Brauch</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Haist-Gulde</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Preuss</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>U.</ce:given-name>
                                 <ce:surname>Wilme</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Zullei-Seibert</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Removal of pharmaceuticals during drinking water treatment</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Environ. Sci. Technol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>36</sb:volume-nr>
                              </sb:series>
                              <sb:date>2002</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>3855</sb:first-page>
                              <sb:last-page>3863</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib31">
                     <ce:label>USEPA, 1998</ce:label>
                     <ce:other-ref>
                        <ce:textref>USEPA, 1998. Stage 1 Disinfectants and Disinfection Byproduct Rule, -63, FR 69390-476.</ce:textref>
                     </ce:other-ref>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib32">
                     <ce:label>USEPA, 1999</ce:label>
                     <ce:other-ref>
                        <ce:textref>USEPA, 1999. Alternative Disinfectants and Oxidants Guidance Manual, EPA 815-R-99-014.</ce:textref>
                     </ce:other-ref>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib33">
                     <ce:label>Webb et al., 2003</ce:label>
                     <sb:reference>
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Webb</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.A.</ce:given-name>
                                 <ce:surname>Ternes</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Gibert</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Olejniczak</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Indirect human exposure to pharmaceuticals via drinking water</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Toxicol. Lett.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>142</sb:volume-nr>
                              </sb:series>
                              <sb:date>2003</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>157</sb:first-page>
                              <sb:last-page>167</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
               </ce:bibliography-sec>
            </ce:bibliography>
         </tail>
      </article>
   </xocs:serial-item></xocs:doc></originalText></full-text-retrieval-response>